Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AADAT	"KAT2, KATII, KYAT2"	ENSG00000109576	"Aminoadipate aminotransferase"	Q8N5Z0	4	170060222-170091699	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 56.5"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 60.6;Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037502	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA037502: AB_10671759"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.17e-2)"	3.0	3.1	9.2	2.2	9.0	0.9	4.7	0.8	10.8	8.3	4.7	10.3	2.9	1.9	9.7	5.8	2.8	5.7	3.9	2.8	7.2	6.4	6.3	56.5	4.7	1.1	8.2	8.0	4.7	4.6	7.6	8.9	2.2	6.0	13.3	5.0	6.6	1.7	5.4	3.6	1.8	2.0	7.0	7.0	2.0	3.2	7.2	9.2	0.9	7.0	1.2	1.3	5.5	4.9	0.4	0.4	0.0	0.7	0.0	0.7	0.0	2.2	5.5	16.7	0.0	3.3	13.0	6.0	5.7	2.8	3.3	3.3	5.3	0.6	0.0	0.9	6.3	4.3	1.9	7.4	2.7	2.3	0.0	6.4	0.0	6.2	8.9	2.7	0.0	2.4	5.3	1.6	2.7	3.5	9.1	3.1	7.5	0.9	0.1	12.6	5.6	2.7	0.1	12.6	6.2	5.0	0.0	5.2	0.0	2.9	10.0	13.5	15.7	4.5	1.1	5.4	5.6	0.0	1.1	2.1	8.4	9.0	9.5	8.8	0.0	0.0	0.0	8.4	0.0	9.8	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.4	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	9.2	9.0	0.8	10.8	7.2	6.4	8.2	8.0	6.0	9.2	0.0	5.1	0.0	2.6	0.8	5.1	1.1	2.5	14.7	3.4	0.0	2.0	1.4	0.0	1.3	0.4	0.5	0.0	0.0	1.9	60.6	2.4	3.6	0.0	22.9	1.4	0.0	6.4	0.0	0.3	0.6	1.1	0.6	1.7	0.0	1.3	3.2	0.9	0.0	2.1	6.5	8.2	6.5	2.2	2.4	12.5	0.4	4.7	0.0	2.3	1.4
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122075647-122144280	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 98.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.6;NTERA-2: 25.0;SuSa: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Enhanced	Vesicles,Mitochondria		Yes	No		17000	Mitochondria	Vesicles	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	13.9	9.5	7.4	4.8	11.8	1.6	11.2	2.7	9.8	16.0	8.1	12.5	8.2	2.2	16.8	11.6	6.4	14.9	6.7	12.6	8.8	3.7	14.4	35.8	9.1	3.3	15.2	5.0	36.7	10.7	14.9	10.4	7.1	9.9	9.2	3.8	9.2	5.4	10.4	11.3	4.4	5.5	9.3	12.1	5.2	9.0	5.1	13.2	0.8	7.8	8.3	3.1	11.0	9.0	1.0	0.4	3.5	0.1	0.3	1.2	0.1	0.1	0.0	15.8	25.6	13.3	8.5	6.2	4.3	4.6	4.5	6.5	7.3	0.2	0.0	0.2	3.0	5.1	2.7	18.3	8.2	6.2	0.0	6.7	5.5	3.5	4.7	10.8	0.0	1.8	7.5	0.2	5.4	5.7	12.6	10.8	7.3	1.4	10.1	3.1	0.0	0.5	0.0	25.0	0.0	1.0	8.3	8.4	0.3	2.1	1.7	1.6	0.5	1.4	0.0	2.6	21.7	0.4	0.0	4.9	8.8	2.7	4.1	4.1	2.2	1.6	0.0	3.2	0.5	3.4	3.5	0.1	0.0	0.7	0.0	0.1	0.5	0.8	0.0	0.4	1.0	1.2	0.5	0.0	0.3	0.0	0.0	0.7	0.1	7.4	11.8	2.7	7.3	8.8	3.7	15.2	5.0	9.9	13.2	8.9	28.6	1.5	8.9	5.6	6.3	8.1	7.6	0.0	7.9	14.0	15.7	9.1	0.0	1.8	9.2	9.2	1.0	0.0	1.5	2.5	9.3	5.2	3.5	98.3	1.2	11.1	2.9	19.6	1.8	5.4	17.5	1.5	11.8	0.0	2.4	8.7	2.6	2.9	23.0	7.8	2.2	19.4	21.6	6.4	1.5	4.1	4.2	2.2	1.5	3.7
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		140000	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	15.0	10.0	28.3	46.8	23.5	14.0	36.1	18.1	22.4	21.1	27.2	28.0	14.5	0.0	18.5	14.1	8.8	11.3	8.8	61.1	19.4	0.0	10.6	2.9	14.9	23.8	11.5	0.0	0.0	17.1	14.4	16.4	11.8	15.6	16.8	0.0	0.0	0.0	18.5	9.9	0.6	0.0	19.1	11.1	8.5	9.0	32.1	0.0	20.0	11.5	9.6	11.5	0.0	10.0	10.5	22.7	18.0	0.6	20.4	6.1	18.9	7.0	12.4	0.0	0.0	0.0	3.3	0.0	9.8	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4	14.9	24.0	11.8	48.6	23.0	22.4	35.5	25.5	20.1	33.0	40.1	21.6	364.8	64.6	31.9	24.9	14.7	17.8	0.0	12.1	88.6	30.8	28.6	6.9	69.5	42.5	23.8	20.8	20.9	9.4	29.5	23.6	7.4	52.3	12.6	22.1	96.8	15.1	8.6	35.0	241.4	12.2	19.4	17.3	1.0	3.1	14.1	185.9	2.5	43.7	34.8
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155562807	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	20.1	10.1	12.1	17.7	14.5	12.3	14.5	23.6	15.5	15.4	17.7	15.5	20.4	8.2	18.7	12.5	12.5	12.2	10.0	11.0	11.8	10.6	13.0	8.9	10.6	9.4	16.6	11.5	23.5	10.0	24.4	22.6	12.9	13.2	18.9	10.7	10.7	11.8	22.2	21.8	12.8	12.8	17.4	14.5	8.6	10.4	7.8	14.3	15.6	16.8	7.1	10.6	17.8	19.9	11.0	5.7	16.5	5.3	8.6	10.7	1.7	13.6	11.7	7.7	6.6	17.4	18.7	8.7	11.1	11.6	7.6	6.4	8.7	9.1	6.1	11.2	14.5	5.8	14.2	12.1	9.7	12.0	6.0	7.8	7.5	11.6	4.7	8.4	8.3	5.9	11.5	10.8	12.7	12.5	11.5	9.0	6.0	10.7	9.2	12.6	10.7	5.6	4.5	7.3	17.0	11.4	5.2	15.9	7.0	8.4	15.1	7.9	11.7	17.5	15.8	8.6	8.4	12.7	18.2	13.8	11.7	12.6	11.1	13.6	8.6	4.9	9.7	9.1	6.3	10.1	16.5	5.3	11.0	8.3	3.2	7.9	10.0	7.8	6.3	2.5	11.0	10.7	5.5	12.8	8.6	3.5	5.7	8.6	1.7	12.1	14.5	23.6	15.2	11.8	10.6	16.6	11.5	13.2	14.3	56.6	88.1	42.2	92.1	92.3	138.8	87.3	43.3	45.5	96.7	48.8	190.5	40.3	14.9	37.0	14.5	82.3	61.6	23.3	34.5	22.1	98.4	94.0	78.6	28.8	21.6	108.1	64.8	59.5	40.8	12.1	94.6	55.1	50.6	62.3	49.5	77.4	31.8	59.1	111.7	23.9	119.9	97.0	97.6	85.7	46.2	97.9	63.7	68.9	46.6	109.1
BBOX1	"BBH, BBOX, G-BBH, gamma-BBH"	ENSG00000129151	"Gamma-butyrobetaine hydroxylase 1"	O75936	11	27040725-27127809	"Enzymes, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 139.4;liver: 39.3"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1023.7"	"Group enriched"	"Detected in many"	6	"glioma: 23.7;renal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTCEpi: 16.2;RPTEC TERT1: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007600, HPA027823"	Enhanced	Approved	Uncertain	"Vesicles,Actin filaments"		NA	NA		25000	Vesicles	"Actin filaments"	"HPA007600: AB_1845284, HPA027823: AB_10602394"	"unprognostic (9.96e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (7.03e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.73e-3)"	0.9	0.5	9.2	0.5	7.1	0.5	8.2	3.9	7.5	1.5	0.6	4.9	0.1	0.5	0.6	3.6	5.7	3.8	3.6	0.5	7.9	6.3	139.4	39.3	0.6	0.6	10.9	4.3	0.5	0.8	0.5	8.3	1.3	9.2	0.7	0.5	0.0	2.2	2.0	0.6	16.4	0.5	0.5	7.1	0.5	0.6	0.6	5.8	0.0	8.9	1.6	0.7	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.0	16.2	0.0	0.0	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.5	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	7.1	3.9	7.5	7.9	6.3	10.9	4.3	9.2	5.8	0.0	1.1	0.0	5.5	7.2	0.0	0.0	17.8	6.7	2.3	43.6	0.0	0.1	189.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	25.4	0.0	0.0	0.0	0.6	1.2	1.1	0.0	0.0	1.7	0.0	0.0	11.3	0.1	0.0	0.4	1023.7	0.3	0.0	0.4	0.0	0.1	31.2	0.2	0.0	0.0	2.2
CERCAM	"CEECAM1, CerCAM, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.1"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 48.9;Fibroblasts: 70.1;Melanocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.6;ASC TERT1: 59.3;fHDF/TERT166: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	12.7	5.1	40.0	7.2	65.5	1.6	9.0	10.0	62.1	19.1	6.9	61.2	5.0	4.8	11.4	10.9	8.2	6.0	17.3	8.8	72.8	34.7	4.9	1.8	5.3	2.3	59.5	28.1	14.1	18.8	15.8	21.6	27.4	31.4	11.1	5.2	3.5	13.2	13.6	4.3	8.9	6.0	27.7	78.1	3.3	5.4	5.2	62.1	0.0	6.7	2.4	2.7	15.1	6.6	0.3	2.0	0.3	1.6	1.1	5.3	2.2	9.5	6.1	6.9	7.3	55.6	59.3	5.9	30.9	29.2	8.1	6.1	2.2	0.4	0.0	12.7	50.4	6.9	6.5	3.0	4.1	3.1	2.4	4.9	0.5	5.6	3.3	17.0	1.1	17.3	32.8	2.2	8.8	2.1	33.5	9.1	0.6	2.8	7.6	10.5	18.1	0.4	11.7	0.4	0.4	4.7	0.9	4.8	1.3	3.8	3.6	1.0	1.9	6.9	8.4	3.5	2.3	6.8	2.3	10.1	21.6	5.9	29.6	4.7	8.9	6.9	0.1	20.4	3.4	4.2	0.3	1.1	0.1	3.8	1.6	0.3	0.3	0.3	4.7	1.5	0.1	0.1	5.3	0.3	1.1	0.1	2.0	0.0	2.2	40.0	65.5	10.0	24.5	72.8	34.7	59.5	28.1	31.4	62.1	6.0	13.0	0.0	6.2	7.9	1.1	3.2	0.0	6.7	21.6	10.4	0.0	14.3	0.0	10.7	2.0	7.1	0.0	0.0	2.9	48.9	70.1	3.9	8.1	0.0	5.9	6.4	0.0	18.4	0.6	1.5	22.5	4.7	38.8	1.0	0.0	0.1	6.9	0.0	24.8	0.5	0.7	6.5	15.6	1.0	19.0	3.6	16.4	2.5	0.0	2.0
COLGALT1	"FLJ22329, GLT25D1"	ENSG00000130309	"Collagen beta(1-O)galactosyltransferase 1"	Q8NBJ5	19	17555594-17583162	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 66.0;Hofbauer cells: 81.3;Kupffer cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047821	Approved		Approved	Vesicles	"Intracellular and membrane"	No	No			Vesicles		"HPA047821: AB_2680168"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (2.92e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (3.83e-4)"	29.8	11.4	12.1	26.9	16.5	21.3	36.2	15.6	13.1	18.2	18.5	10.8	9.6	12.0	21.9	20.2	17.6	19.2	18.1	21.7	10.8	7.1	11.1	17.8	25.1	46.1	19.4	7.3	19.0	15.2	7.9	8.1	29.6	11.8	12.6	11.6	9.5	12.0	13.0	10.7	16.7	17.3	25.7	11.3	30.9	13.9	11.2	17.9	10.3	11.3	12.7	11.9	19.6	19.1	2.5	11.5	7.6	17.4	1.4	3.6	7.1	23.2	27.5	13.4	18.4	53.2	33.0	21.4	21.8	12.8	28.8	29.9	20.8	36.7	11.9	39.1	38.2	24.6	20.8	13.6	25.3	17.5	6.7	21.8	11.4	35.8	19.7	29.2	27.2	34.9	27.3	22.7	32.2	13.5	11.7	32.3	7.6	23.3	6.0	10.4	10.2	13.7	17.6	9.9	16.9	26.9	14.7	17.1	18.2	6.1	15.5	9.7	7.0	23.4	18.7	22.1	9.1	9.7	39.7	22.5	57.2	16.2	50.7	35.4	10.8	27.3	13.1	33.8	51.9	25.9	1.1	15.0	7.6	3.4	17.4	2.0	2.3	3.2	3.2	11.5	2.5	2.3	3.6	2.4	1.4	12.6	4.4	1.9	7.1	12.1	16.5	15.6	13.1	10.8	7.1	19.4	7.3	11.8	17.9	17.9	30.0	6.0	4.6	17.3	3.6	8.9	5.1	5.3	18.2	10.4	5.9	5.4	0.0	11.4	2.7	14.6	9.7	0.0	6.9	66.0	26.7	5.5	8.1	12.3	81.3	12.7	5.2	9.2	58.8	2.3	17.5	43.3	16.9	8.2	13.7	1.7	10.2	5.8	20.5	4.1	2.9	12.9	17.3	3.1	13.9	18.2	7.0	10.2	15.3	7.5
COLGALT2	"C1orf17, GLT25D2, KIAA0584"	ENSG00000198756	"Collagen beta(1-O)galactosyltransferase 2"	Q8IYK4	1	183929854-184037729	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 38.2;Late spermatids: 52.3;Sertoli cells: 12.9"	"Cancer enhanced"	"Detected in many"		"glioma: 11.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 12.7;OE19: 10.2;SK-MEL-30: 13.7;U-251 MG: 13.1;WM-115: 16.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031749, HPA031750"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Nucleoplasm	Vesicles	"HPA031749: AB_10599298, HPA031750: AB_10611252"	"unprognostic (5.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.29e-5)"	"unprognostic (2.08e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.13e-9)"	"unprognostic (1.53e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.80e-2)"	2.1	9.4	10.8	1.7	16.6	1.9	2.8	10.6	39.0	2.0	3.0	31.3	0.0	1.4	3.0	5.2	1.7	3.5	3.7	11.7	15.3	7.9	1.8	1.0	4.5	1.1	20.2	12.9	2.3	3.5	1.0	1.9	0.8	17.4	8.1	2.0	3.5	4.4	3.7	11.0	1.1	1.4	3.0	21.8	1.3	3.4	5.0	22.5	0.0	5.1	1.8	1.5	2.4	1.4	0.0	0.0	8.1	0.0	0.7	0.6	0.1	0.1	0.0	4.4	0.2	2.3	3.4	0.1	1.2	0.5	0.6	0.7	2.1	0.2	0.0	0.3	3.3	0.8	0.0	4.2	0.0	1.1	4.6	2.3	0.3	0.0	12.7	0.1	4.1	0.0	2.0	0.0	0.6	0.1	6.4	0.0	0.1	4.1	5.4	4.6	0.1	0.2	0.2	3.0	10.2	0.0	0.4	0.0	0.0	0.0	0.9	1.7	2.7	0.2	0.0	13.7	2.9	0.0	0.2	0.0	0.5	0.4	0.0	13.1	8.0	0.0	0.0	0.4	2.0	16.9	8.1	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	10.8	16.6	10.6	17.2	15.3	7.9	20.2	12.9	17.4	22.5	0.0	0.0	0.0	0.4	0.3	0.8	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	38.2	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	52.3	2.0	1.5	1.7	0.0	0.0	4.8	1.0	0.0	3.9	0.2	0.2	12.9	0.5	0.3	0.4	0.4	0.0	3.5	0.0	0.3
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636360-133659344	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 86.6;brain: 36.2;liver: 35.6"	"Cell type enriched"	"Detected in single"	43	"Ito cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	45	"pons and medulla: 36.2"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Cell line enriched"	"Detected in single"	340	"SH-SY5Y: 206.1"	"Region enriched"	"Detected in some"	6	"pons and medulla: 23.2"	"Region enriched"	"Detected in single"	38	"pons and medulla: 25.1"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		2000000000	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	0.7	86.6	0.1	0.3	0.1	0.0	0.0	0.1	0.8	0.3	0.0	1.9	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.5	35.6	0.3	0.6	0.0	0.0	0.1	1.3	0.0	0.6	0.4	36.2	0.8	0.0	1.0	0.2	5.9	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.2	206.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068972-12123225	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.5"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 213.4;Proximal tubular cells: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617"	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	5.7	6.3	6.5	4.7	6.6	2.2	5.0	5.7	7.2	5.5	5.7	9.8	5.0	4.5	4.7	5.0	5.1	4.2	4.5	7.7	5.3	4.8	23.8	69.5	4.2	6.9	7.5	5.2	7.1	16.6	5.4	4.1	4.7	6.2	7.6	6.3	7.2	9.7	7.1	10.5	3.6	4.3	3.5	6.1	5.1	6.1	4.4	6.6	10.1	6.8	6.7	8.0	5.2	4.1	9.5	12.5	16.8	11.0	10.2	4.1	3.3	11.4	8.8	13.2	10.5	8.2	4.9	16.0	5.8	3.7	10.4	9.2	5.6	6.9	8.3	1.9	3.6	4.8	16.3	13.8	4.5	11.9	4.6	6.2	4.5	3.5	4.3	8.1	1.8	1.7	6.0	3.5	6.0	2.4	4.1	5.6	10.1	7.0	6.7	2.8	22.2	6.0	3.2	7.3	10.6	2.1	10.3	4.3	7.0	6.7	2.7	3.4	15.5	11.4	20.4	6.8	14.8	45.0	6.5	2.5	3.4	2.5	7.0	4.2	6.0	4.2	5.3	4.3	3.2	5.6	16.8	4.8	10.7	3.2	6.8	3.4	9.5	2.5	2.1	8.6	7.8	2.5	3.3	14.0	10.2	11.0	12.5	4.1	3.3	6.5	6.6	5.7	7.2	5.3	4.8	7.5	5.2	6.2	6.6	11.9	32.1	21.6	5.5	4.6	11.5	26.6	25.5	5.3	6.8	15.7	9.8	22.3	16.6	9.3	2.6	7.4	10.3	0.0	9.7	18.5	6.6	11.2	8.1	213.4	8.4	25.4	10.9	11.6	11.9	3.1	11.5	11.3	5.0	13.6	19.6	10.8	9.7	10.5	11.3	55.4	18.7	12.9	5.0	5.6	3.6	5.3	11.3	7.1	15.0	6.2
DLD	"DLDH, GCSL, LAD"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107890970-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		16000000	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	25.7	37.9	14.5	12.7	25.4	12.0	15.2	16.6	27.2	13.2	28.0	10.6	12.2	20.9	13.6	9.6	25.6	11.6	12.7	69.1	16.4	14.4	40.7	37.9	11.0	13.0	16.7	20.1	15.1	14.8	24.6	22.4	15.4	29.3	14.7	26.8	12.8	19.4	14.4	71.5	13.8	29.5	23.7	10.6	17.4	23.0	10.6	10.7	18.7	17.0	31.8	16.9	20.1	11.7	13.5	30.4	45.8	37.8	22.9	19.4	20.2	40.1	32.6	18.1	31.1	26.0	23.0	20.5	23.1	19.5	26.9	20.9	38.0	22.6	39.3	39.9	24.5	44.0	26.7	36.3	32.6	40.7	26.2	21.6	27.6	43.2	27.1	20.0	45.4	28.5	26.2	23.7	28.6	15.6	17.1	32.3	33.0	68.9	29.3	29.2	45.1	37.1	32.9	21.5	48.5	23.7	26.8	29.0	53.3	36.8	60.0	22.5	23.8	37.8	64.0	34.0	37.6	24.4	38.9	20.4	29.8	24.4	57.9	35.1	22.2	42.3	26.4	28.0	48.5	30.7	36.5	22.3	45.8	17.5	28.2	18.5	13.5	17.7	17.3	30.4	12.3	18.7	19.4	14.0	22.9	37.8	10.5	16.8	20.2	14.5	25.4	16.6	27.2	16.4	14.4	16.7	20.1	29.3	10.7	26.8	16.5	23.1	30.6	27.8	45.9	284.8	61.1	37.5	18.2	75.0	21.6	94.8	192.3	59.5	3.8	30.0	47.9	46.7	49.3	49.9	26.3	23.6	26.5	77.8	61.0	20.6	29.4	27.6	36.8	5.6	21.6	34.1	35.4	65.9	39.3	31.3	37.7	56.1	39.6	134.4	33.4	25.8	43.4	41.2	52.4	28.2	90.6	27.7	64.6	28.5
DLST	DLTS	ENSG00000119689	"Dihydrolipoamide S-succinyltransferase"	P36957	14	74881891-74903745	"Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003010	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		800000	"Nucleoplasm, Mitochondria"		"HPA003010: AB_1078679"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.13e-12)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.55e-3)"	32.2	38.6	12.0	22.7	19.9	28.5	31.3	19.1	25.6	31.2	36.0	18.5	15.9	24.7	26.3	28.3	31.4	19.2	29.7	47.6	10.8	11.8	43.7	45.1	20.8	26.7	13.5	13.7	21.5	27.1	25.8	16.2	25.2	19.7	20.9	26.8	19.2	22.3	20.1	59.2	26.9	43.2	32.9	11.4	20.8	24.3	21.0	10.4	23.5	27.2	49.8	28.4	26.9	21.1	3.8	6.3	8.4	4.3	7.7	5.3	3.2	25.8	27.0	20.7	14.6	32.5	36.9	31.7	33.8	34.4	34.6	32.4	26.5	28.1	26.3	14.4	38.8	15.6	29.2	34.8	33.4	36.6	19.0	14.6	21.5	22.6	23.2	33.6	15.2	14.8	37.7	29.3	33.5	41.4	31.2	35.6	11.9	16.4	17.9	37.5	34.7	18.0	21.6	17.7	45.7	25.4	23.1	30.4	14.5	42.9	31.8	24.6	20.9	31.9	42.6	22.0	19.3	39.0	22.0	31.5	21.1	27.6	25.7	23.1	12.7	13.2	23.1	30.8	15.8	22.0	8.4	3.0	5.0	5.0	4.3	4.5	3.8	4.5	3.9	4.7	2.7	4.0	5.3	3.0	7.7	3.9	6.3	4.4	3.2	12.0	19.9	19.1	25.6	10.8	11.8	13.5	13.7	19.7	10.4	6.0	4.5	20.7	19.3	23.5	17.5	23.4	20.4	2.7	3.4	19.2	29.5	33.7	48.0	32.5	6.2	14.6	39.3	0.0	22.3	30.6	23.8	21.8	20.7	37.3	28.4	12.7	14.3	24.5	16.2	3.4	16.7	16.5	21.9	36.1	28.3	8.5	35.0	25.9	19.4	51.5	20.0	25.8	17.9	9.3	11.7	24.8	66.5	20.3	36.1	20.8
DOT1L	"DOT1, KIAA1814, KMT4"	ENSG00000104885	"DOT1 like histone lysine methyltransferase"	Q8TEK3	19	2164149-2232578	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.7"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011875, HPA071217, HPA074977"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: "	"unprognostic (1.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.25e-3)"	"unprognostic (8.18e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	7.3	8.8	7.0	10.7	11.7	20.1	5.1	20.6	11.7	4.5	7.9	9.8	6.0	13.5	6.4	4.9	8.3	5.4	6.9	5.7	7.0	3.6	9.5	8.5	10.0	8.4	11.9	5.3	6.5	10.8	3.6	8.3	11.6	7.1	5.7	4.9	9.5	6.1	7.4	9.8	9.9	13.0	4.2	6.7	10.4	13.3	64.7	9.7	10.5	9.2	7.0	9.1	4.8	5.3	0.7	1.0	3.0	0.9	2.8	1.4	0.6	12.2	6.6	22.4	12.2	1.7	2.5	29.5	7.0	1.5	3.8	3.1	8.4	4.6	14.4	3.4	4.5	3.3	11.0	7.4	3.9	1.8	7.3	9.3	13.2	10.8	8.2	2.7	18.9	24.4	2.4	2.9	7.4	3.8	3.1	3.1	8.2	16.0	15.1	3.0	7.0	15.1	20.9	17.3	7.8	11.8	15.6	6.3	9.9	2.1	5.8	15.0	11.6	4.9	14.6	9.2	6.2	6.7	14.5	4.4	10.7	9.8	15.8	13.4	14.0	18.3	10.0	10.6	13.1	6.2	0.5	0.7	3.0	0.9	0.3	1.4	0.7	0.8	0.2	0.9	0.7	0.5	0.3	0.3	2.8	0.9	1.0	0.1	0.6	7.0	11.7	20.6	11.7	7.0	3.6	11.9	5.3	7.1	9.7	29.8	18.9	9.9	9.3	15.8	25.0	5.2	20.4	6.7	6.8	8.7	62.8	5.3	3.3	10.1	25.8	7.1	25.4	0.0	10.4	11.3	11.0	12.4	5.8	13.1	9.3	12.7	20.0	6.7	11.9	11.9	2.8	14.6	11.8	5.4	10.8	7.3	14.1	14.0	3.2	2.2	26.6	0.0	8.1	28.3	23.5	17.3	13.6	4.9	11.7	14.2
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618963-137870016	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060022, HPA074729"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA060022: AB_2684190, HPA074729: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	16.6	18.3	16.4	23.2	22.3	24.9	17.1	23.7	20.4	16.3	20.7	21.6	20.4	17.1	22.0	13.0	17.9	18.5	20.0	12.1	12.8	9.6	12.7	14.9	14.9	25.0	27.8	12.1	21.4	13.6	15.1	16.2	17.9	18.6	16.9	12.4	19.1	16.5	18.0	23.1	17.3	17.9	21.5	12.5	22.1	16.4	30.8	21.5	22.3	18.9	11.0	22.2	19.2	15.7	20.0	19.0	25.0	13.7	13.1	15.6	6.9	11.1	22.4	25.1	23.3	10.7	11.1	21.1	14.8	9.4	10.8	8.9	14.6	14.0	34.3	14.4	11.2	13.1	24.1	15.0	16.2	8.6	19.2	10.6	14.5	22.4	9.3	9.3	22.0	17.4	9.9	11.4	13.1	12.8	8.0	17.8	13.0	21.7	11.9	7.7	25.8	25.8	10.9	24.5	17.7	14.9	33.2	21.6	19.8	9.1	20.6	22.3	18.1	28.1	19.8	6.4	18.8	22.2	17.8	16.7	12.8	13.3	19.6	14.0	7.6	21.1	28.3	9.5	11.8	13.8	13.6	13.7	16.3	15.6	11.7	10.0	13.3	13.5	13.3	10.4	20.0	13.3	11.8	25.0	13.1	12.0	19.0	11.1	6.9	16.4	22.3	23.7	20.4	12.8	9.6	27.8	12.1	18.6	21.5	17.9	16.3	36.9	20.3	15.5	38.3	24.3	17.8	21.4	22.7	21.0	49.1	18.6	3.3	20.9	68.8	24.8	19.8	0.0	18.3	18.0	18.4	25.8	17.4	28.8	17.0	47.7	27.0	17.8	23.4	119.3	33.1	16.5	11.8	23.4	20.2	23.1	20.1	25.9	35.3	11.9	48.0	12.9	15.3	58.1	54.9	17.7	22.2	23.3	20.5	22.0
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 10.3;NTERA-2: 15.8;U-266/84: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA050550: AB_2681170, HPA060259: AB_2684234"	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	9.4	12.2	13.1	9.6	21.4	7.6	6.3	17.1	17.5	8.0	7.7	12.3	8.4	14.6	15.0	11.7	18.0	7.6	8.1	7.6	12.3	12.4	5.3	4.4	8.5	6.9	12.6	10.6	10.6	13.2	2.2	8.1	6.0	10.3	10.4	4.3	7.2	5.6	9.6	5.2	5.5	10.1	9.6	8.4	9.1	9.8	7.6	14.9	14.6	9.5	4.8	7.2	8.7	7.6	0.3	0.6	0.0	0.7	0.1	1.1	1.3	0.0	3.6	6.4	0.0	2.8	1.5	4.1	2.8	2.3	3.2	2.6	0.0	0.0	0.0	6.3	4.5	3.3	0.0	0.0	6.9	1.5	4.2	9.6	0.0	0.0	0.0	0.0	10.3	0.0	3.9	1.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	7.3	0.0	15.8	0.0	0.0	6.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.8	5.3	2.7	0.0	0.0	3.0	3.4	2.6	5.7	0.0	9.1	12.4	3.0	3.9	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.1	0.8	0.6	0.3	0.3	1.1	1.1	0.0	0.1	0.7	0.6	0.2	1.3	13.1	21.4	17.1	16.5	12.3	12.4	12.6	10.6	10.3	14.9	14.9	11.8	22.3	5.6	7.4	59.2	4.5	22.9	9.4	19.4	24.4	39.3	19.7	6.6	12.9	33.8	11.9	8.9	0.0	10.6	12.5	13.2	5.8	13.9	6.4	14.1	36.5	21.7	20.3	9.1	44.9	25.3	9.9	18.6	16.2	15.5	28.2	11.0	5.8	21.5	7.8	48.2	25.8	8.5	6.1	30.6	9.7	4.7	14.9	15.0	2.6
EZH1	"KIAA0388, KMT6B"	ENSG00000108799	"Enhancer of zeste 1 polycomb repressive complex 2 subunit"	Q92800	17	42700275-42745049	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Rod photoreceptor cells: 268.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005478, HPA077684"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005478: AB_1848340, HPA077684: AB_2732356"	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.74e-2)"	21.7	10.4	15.0	10.1	25.0	9.9	18.7	39.6	26.1	18.4	15.1	21.4	10.0	9.7	29.8	21.2	10.6	18.8	9.7	17.2	19.0	11.2	13.6	5.3	12.6	14.0	13.7	22.0	38.2	8.1	20.0	19.1	9.3	25.6	13.1	12.1	21.5	10.7	19.3	25.4	16.0	14.0	16.4	19.9	16.0	10.6	8.6	16.7	11.9	15.0	7.5	14.9	16.0	15.9	6.2	6.0	18.8	5.4	4.8	8.3	2.3	5.5	5.8	8.0	5.5	32.1	19.4	6.8	8.9	8.2	7.4	7.6	2.7	6.9	8.4	5.6	9.4	7.3	12.6	5.2	5.9	10.7	9.3	9.3	2.9	10.8	3.3	11.0	6.2	7.0	11.1	10.8	5.6	13.6	13.0	6.0	8.5	7.6	11.9	6.5	2.3	10.1	8.0	2.2	5.1	3.0	6.6	8.2	8.9	7.7	5.9	5.5	4.4	4.9	2.4	5.9	11.9	8.5	4.0	6.2	8.0	3.3	9.3	5.6	12.5	6.3	5.0	5.7	6.5	4.0	10.2	5.2	6.9	5.9	5.4	8.3	5.7	5.2	6.0	1.9	6.2	7.7	5.7	18.8	4.8	3.3	6.0	5.7	2.3	15.0	25.0	39.6	26.1	19.0	11.2	13.7	22.0	25.6	16.7	8.9	17.3	10.7	12.1	4.6	67.2	34.7	17.8	38.8	17.0	12.2	62.8	6.1	8.3	9.2	0.4	12.2	6.7	46.7	6.4	2.6	7.5	7.2	19.7	6.7	7.7	44.5	12.5	15.4	11.6	1.1	28.7	10.6	1.7	20.8	4.2	32.0	9.4	6.0	32.2	8.1	268.1	51.8	13.3	9.3	8.8	5.4	9.0	15.9	6.8	7.6
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.5;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 72.2;Spermatocytes: 126.7;Spermatogonia: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009589	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009589: "	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (8.18e-12)"	"prognostic favorable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	2.0	1.7	1.8	10.6	1.6	25.5	1.4	4.9	2.7	2.6	4.8	1.1	0.1	3.8	1.7	2.8	11.0	0.9	3.0	0.9	0.8	0.6	1.7	3.3	2.3	12.6	1.3	0.3	2.2	3.8	0.6	1.7	3.4	1.4	1.4	5.1	1.8	3.2	1.6	3.7	6.4	4.8	1.5	1.2	5.8	2.7	19.6	1.3	44.1	0.9	5.5	12.4	2.6	3.5	1.5	4.7	1.3	3.9	8.5	10.3	1.7	17.0	8.0	27.3	18.2	0.8	1.4	14.9	13.3	5.4	11.0	11.1	12.0	19.7	30.2	6.5	5.0	10.0	10.5	14.0	4.6	14.0	43.2	14.0	12.9	9.9	9.3	2.2	28.6	10.6	1.2	2.6	8.2	4.4	3.3	6.4	29.3	27.3	20.1	9.8	19.3	55.6	23.9	21.7	15.0	10.8	34.4	15.3	18.7	5.1	8.2	26.1	16.6	16.7	12.7	4.4	7.3	9.3	12.3	3.9	11.7	5.4	23.3	23.8	18.0	19.6	30.4	10.7	19.6	22.9	0.5	2.2	1.3	1.7	1.5	1.3	1.5	3.4	2.9	4.7	0.8	1.9	1.2	0.2	8.5	3.9	1.0	10.3	1.7	1.8	1.6	4.9	2.7	0.8	0.6	1.3	0.3	1.4	1.3	0.0	7.9	6.7	5.7	23.6	4.8	6.5	2.5	14.7	7.9	7.0	33.4	13.6	3.3	9.1	72.2	7.1	6.7	23.3	7.4	29.5	10.8	4.4	21.8	1.3	10.4	14.3	8.6	4.3	8.9	19.2	2.8	10.9	13.5	19.0	10.2	2.0	10.1	9.3	0.7	1.0	21.1	6.5	9.9	126.7	62.4	25.3	25.5	18.7	18.6	4.0
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: AB_2679141"	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	14.4	11.3	17.7	17.0	19.2	28.6	16.8	43.8	21.2	17.3	14.6	19.8	18.1	8.5	21.8	17.1	10.6	15.7	14.1	10.2	17.3	13.4	13.1	9.3	15.3	19.6	16.6	18.7	35.6	16.8	28.9	21.8	10.2	15.4	15.6	12.4	14.4	14.2	19.2	11.1	16.8	14.2	15.2	12.1	15.7	12.3	7.9	23.4	16.6	16.6	7.8	19.4	18.8	24.6	6.7	3.5	8.3	2.0	6.5	5.3	0.8	12.1	5.6	15.2	11.4	9.3	11.1	4.5	5.5	8.0	5.8	6.7	11.3	8.8	15.0	11.3	8.0	10.3	10.6	16.1	6.1	11.6	16.5	6.2	29.4	5.2	6.1	5.2	17.5	5.7	5.3	6.2	12.7	17.0	7.3	9.0	9.8	19.1	12.8	7.3	9.5	11.6	10.3	9.2	5.0	8.4	8.8	14.6	5.0	8.5	9.2	12.5	8.1	13.8	4.5	2.9	8.3	7.8	5.9	13.2	9.9	9.0	7.2	9.8	3.7	2.9	10.1	3.7	12.9	5.9	8.3	2.0	4.6	5.3	1.3	4.3	6.2	4.8	4.6	0.8	6.7	4.9	4.8	1.3	6.5	1.4	3.5	3.9	0.8	17.7	19.2	43.8	21.2	17.3	13.4	16.6	18.7	15.4	23.4	65.5	59.8	31.5	64.8	77.2	147.8	34.4	38.2	53.5	35.2	36.6	143.3	12.2	3.3	26.8	6.6	70.1	19.7	0.0	22.3	8.1	43.5	71.4	26.7	23.1	14.2	184.3	63.8	45.4	32.6	4.7	61.9	26.1	40.5	33.3	29.3	117.0	23.2	14.4	73.9	6.9	144.6	64.7	59.7	11.1	14.9	70.4	5.0	50.7	27.3	49.9
KMT2B	"CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7"	ENSG00000272333	"Lysine methyltransferase 2B"	Q9UMN6	19	35718019-35738878	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 61.2;Rod photoreceptor cells: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006487			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006487: AB_1080587"	"unprognostic (1.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.33e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.63e-3)"	"unprognostic (9.47e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	10.2	9.3	11.4	14.2	13.1	18.4	10.4	23.9	11.4	10.0	12.0	14.2	12.9	13.8	13.0	7.1	11.4	11.6	12.6	7.5	11.0	5.3	9.9	8.9	10.6	14.7	14.7	6.8	15.3	19.6	10.8	13.3	9.3	11.2	12.1	5.6	13.8	14.7	10.0	13.3	19.9	12.3	12.2	12.4	15.8	12.1	21.5	14.9	14.1	14.9	7.0	14.2	12.4	14.2	0.4	0.7	3.2	0.7	2.1	0.7	0.2	11.5	19.5	9.0	9.9	4.7	4.6	9.4	5.6	4.1	5.7	4.4	13.0	5.9	10.3	8.8	4.6	6.1	7.6	8.1	4.8	2.5	15.2	9.0	18.5	9.1	6.5	4.6	11.2	21.2	6.2	6.5	5.8	6.4	5.1	5.5	10.7	15.4	12.9	3.7	11.8	9.5	9.7	8.3	10.0	6.9	15.0	5.9	5.6	3.1	10.3	10.2	8.2	8.5	13.8	5.9	5.0	8.4	12.0	7.7	11.4	12.4	7.6	11.8	17.8	10.9	8.2	6.2	10.4	7.9	1.0	0.7	0.6	0.7	0.4	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.4	3.2	2.1	0.3	0.7	0.2	0.2	11.4	13.1	23.9	11.4	11.0	5.3	14.7	6.8	11.2	14.9	8.9	19.1	13.3	8.5	11.3	61.2	7.7	10.2	4.0	5.7	8.7	49.1	5.2	0.0	5.5	2.1	11.7	14.0	0.0	6.7	4.9	8.1	13.1	4.7	9.7	7.3	33.4	19.4	11.6	8.7	4.1	7.5	6.4	5.0	6.4	10.4	27.2	7.1	11.4	11.7	4.2	74.2	0.0	8.2	28.1	36.4	11.3	7.9	10.2	11.3	12.8
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436005	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074736: AB_2686709"	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	13.9	12.6	11.7	16.7	18.6	29.7	14.5	24.8	14.1	18.4	12.6	15.5	21.4	9.7	20.2	20.6	14.4	12.8	12.7	10.8	13.4	9.5	10.3	11.4	13.0	12.1	17.7	9.4	18.8	18.4	18.8	18.9	38.0	12.6	14.0	11.8	12.6	15.8	22.9	30.3	25.2	13.1	13.6	16.0	14.6	14.9	13.6	19.6	22.6	16.9	9.3	16.8	17.8	31.6	5.6	3.5	16.1	3.9	5.5	2.9	0.6	9.7	4.9	9.1	9.7	16.5	10.0	10.7	5.1	3.9	4.1	5.0	9.3	5.9	15.5	7.4	9.2	5.6	5.6	9.8	7.4	6.9	9.8	5.0	9.2	7.4	6.4	8.0	15.5	11.3	8.4	10.3	5.8	7.8	6.6	5.8	8.1	14.8	13.4	8.9	13.6	11.2	14.1	5.5	7.6	4.9	7.6	8.3	8.1	7.0	10.0	13.3	10.5	8.4	15.0	5.5	9.9	4.9	12.8	7.3	6.8	3.6	7.3	7.2	14.1	6.9	16.7	8.9	12.8	7.0	8.8	3.5	4.3	2.1	2.2	2.9	5.6	1.7	1.7	1.7	3.8	2.7	1.8	16.1	5.5	3.9	3.5	1.3	0.6	11.7	18.6	24.8	14.1	13.4	9.5	17.7	9.4	12.6	19.6	71.5	66.6	54.7	36.1	79.1	82.8	58.2	45.9	44.2	92.1	43.6	163.0	29.7	5.0	30.2	18.6	49.2	41.0	23.3	28.7	45.7	47.0	48.1	62.5	36.6	29.6	76.3	65.1	41.7	48.8	11.0	62.5	61.0	40.5	25.2	44.5	62.2	33.0	43.8	56.6	15.7	75.2	25.8	50.1	33.5	31.5	84.2	106.4	50.4	30.3	55.0
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018975-49059774	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	12.1	7.6	4.9	6.7	10.8	26.1	6.8	11.7	10.5	9.5	6.5	5.8	13.0	5.5	15.7	7.4	8.8	8.9	5.8	9.1	6.1	3.5	6.2	6.5	22.9	9.6	6.7	3.3	9.7	11.6	13.3	9.2	12.9	13.7	6.7	6.6	9.8	7.6	8.0	16.1	13.6	9.4	7.1	9.1	13.6	8.3	7.3	5.7	6.2	11.0	6.1	7.6	7.0	6.3	2.0	2.2	5.9	0.5	1.5	0.8	0.6	17.1	16.3	16.5	13.3	17.1	11.5	17.7	9.1	9.5	11.8	6.3	28.6	7.3	17.8	11.8	12.7	8.5	11.6	21.7	10.0	9.8	10.4	17.4	22.6	17.1	15.3	11.7	26.8	22.7	9.7	14.4	16.5	17.1	14.1	17.5	18.5	28.3	9.9	13.3	18.9	13.3	25.0	15.6	23.7	14.1	20.0	10.2	6.4	9.9	19.0	13.8	11.7	14.0	13.8	9.5	15.0	13.7	23.5	23.3	9.3	16.6	8.1	15.2	14.1	9.1	17.3	10.7	13.9	6.9	0.6	0.5	3.0	0.8	0.2	0.4	0.3	0.3	0.5	0.3	2.0	0.3	0.8	5.9	1.5	0.1	2.2	0.0	0.6	4.9	10.8	11.7	10.5	6.1	3.5	6.7	3.3	13.7	5.7	8.9	18.4	11.1	6.5	12.5	25.2	4.7	12.7	5.3	9.1	17.4	49.1	6.6	1.7	5.8	2.5	12.6	11.1	0.0	5.2	4.6	8.5	8.3	8.1	12.3	8.3	20.6	12.6	17.2	19.7	1.1	8.9	9.6	10.1	4.6	10.5	5.2	7.2	8.6	10.3	4.3	38.9	6.5	3.3	3.7	3.2	15.4	9.5	10.4	10.1	8.4
KMT2E	"HDCMC04P, MLL5"	ENSG00000005483	"Lysine methyltransferase 2E"	Q8IZD2	7	105014179-105114361	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042866, HPA056125"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA042866: , HPA056125: AB_2683044"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	22.7	11.8	18.6	24.5	23.5	44.8	20.9	41.6	22.4	26.4	20.9	18.6	21.7	14.7	25.3	15.8	16.5	18.6	18.2	16.8	20.6	15.1	14.2	11.6	22.8	20.1	22.7	17.4	33.5	15.6	20.5	20.1	18.7	18.6	21.2	20.5	17.6	19.6	19.2	21.3	25.7	18.5	26.2	23.1	21.6	17.9	12.9	27.2	24.6	21.7	15.1	22.7	26.6	21.4	38.2	24.7	72.9	20.8	20.3	30.6	14.7	15.1	10.7	22.7	19.5	14.1	16.9	5.8	11.6	17.4	9.8	12.1	8.7	13.9	12.6	11.6	13.6	13.2	11.8	12.5	11.5	16.3	20.3	7.2	12.7	14.0	7.4	13.3	17.0	16.0	11.8	10.8	13.6	14.6	17.9	17.7	14.1	17.3	36.1	13.8	11.9	27.1	14.6	7.9	8.3	8.6	23.4	14.0	14.6	9.7	15.4	13.0	15.7	16.1	13.9	8.8	15.9	6.0	10.2	21.8	23.2	16.2	26.5	11.5	27.6	21.8	29.1	15.2	13.0	15.9	48.5	18.0	39.4	30.6	13.6	30.3	35.6	28.4	26.1	12.8	38.2	28.0	26.0	72.9	20.3	20.8	24.7	23.6	14.7	18.6	23.5	41.6	22.4	20.6	15.1	22.7	17.4	18.6	27.2	131.0	136.3	133.9	100.8	130.3	219.2	86.5	76.5	84.3	142.1	109.9	237.6	33.5	29.9	70.0	19.2	197.7	91.8	93.5	59.6	38.6	151.9	115.7	236.2	33.7	53.7	174.8	96.0	86.5	76.0	18.6	130.6	138.7	133.3	110.0	88.5	114.4	63.9	84.2	123.8	28.6	269.1	122.9	222.6	98.9	71.7	117.7	54.6	186.4	107.4	119.5
KMT5A	"PR-Set7, SET07, SET8, SETD8"	ENSG00000183955	"Lysine methyltransferase 5A"	Q9NQR1	12	123383773-123409358	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064495			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA064495: AB_2685273"	"unprognostic (5.62e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (3.88e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.75e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.06e-1)"	7.6	5.4	8.9	14.0	7.5	20.2	7.9	9.8	14.1	13.9	9.1	9.9	21.4	7.3	15.7	9.5	22.3	12.3	8.3	10.9	8.1	5.5	6.7	7.4	8.7	8.4	7.8	10.6	7.2	13.1	6.8	7.4	9.9	12.8	18.6	9.1	7.9	19.3	12.5	13.6	15.6	9.1	11.0	10.3	13.3	9.0	5.2	8.6	42.2	17.2	8.9	19.7	12.3	14.2	3.5	3.8	7.8	3.8	4.1	5.4	0.6	12.4	7.9	9.5	14.6	6.1	10.9	13.0	18.6	8.9	10.8	9.5	9.0	7.3	28.7	10.8	12.3	4.0	11.6	13.6	6.8	11.6	12.1	14.1	24.1	8.3	4.5	9.1	18.7	6.1	4.6	8.6	11.7	10.9	10.4	8.8	12.3	43.6	13.4	8.8	9.0	18.9	27.9	4.4	11.3	9.0	22.5	8.1	7.8	7.5	15.2	13.0	10.2	18.5	9.4	8.5	8.8	13.1	23.9	11.2	12.2	8.9	14.5	13.3	7.5	7.8	26.3	8.4	9.8	10.2	4.1	2.5	7.8	2.8	3.8	5.4	3.5	3.3	4.3	2.0	2.3	1.8	2.3	3.4	4.1	3.6	3.8	2.7	0.6	8.9	7.5	9.8	14.1	8.1	5.5	7.8	10.6	12.8	8.6	11.9	12.6	0.0	14.2	0.0	19.6	0.0	5.1	21.4	12.5	26.2	5.9	10.7	6.6	8.0	7.4	11.3	8.5	0.0	8.1	13.9	8.7	20.1	2.3	13.4	15.1	3.2	4.7	28.8	17.1	2.1	15.0	10.3	0.0	1.0	28.5	22.4	11.3	10.5	40.3	8.3	16.8	6.5	0.0	8.9	11.7	0.0	11.9	8.2	12.4	19.3
KMT5B	"CGI-85, SUV420H1"	ENSG00000110066	"Lysine methyltransferase 5B"	Q4FZB7	11	68154863-68213828	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063648			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063648: AB_2685073"	"unprognostic (5.82e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (9.30e-4)"	17.6	19.1	20.9	23.4	22.5	23.7	27.3	38.8	26.7	22.4	21.2	19.9	32.3	21.8	26.2	22.7	19.7	20.4	18.2	15.1	23.8	15.3	19.1	21.5	17.4	16.9	18.6	22.2	27.4	24.0	27.4	28.1	26.6	17.0	24.9	21.5	15.4	25.2	30.4	18.8	20.8	24.0	23.4	18.4	19.6	19.7	19.1	23.6	38.0	30.9	17.5	19.1	20.5	22.5	4.5	5.5	16.0	5.2	8.9	5.9	2.7	10.3	7.8	16.0	10.3	3.7	9.4	17.3	7.5	5.2	9.3	5.5	24.6	16.6	8.5	13.0	10.1	9.2	5.4	11.0	8.6	13.6	9.5	6.4	8.0	9.2	10.1	13.6	11.2	11.0	9.3	17.8	11.2	11.8	8.6	9.2	8.5	11.8	9.9	7.9	21.3	7.9	11.8	17.1	20.7	5.9	13.1	12.5	22.6	6.9	10.0	14.0	16.7	11.5	11.6	52.3	9.1	14.9	7.4	9.6	12.6	16.8	9.6	7.5	12.7	5.5	17.9	7.9	7.1	13.4	7.8	3.7	16.0	4.7	5.2	3.3	3.4	5.1	5.7	3.6	4.5	5.9	5.2	11.3	8.9	4.8	5.5	4.0	2.7	20.9	22.5	38.8	26.7	23.8	15.3	18.6	22.2	17.0	23.6	56.6	48.3	13.8	31.8	0.0	45.8	0.0	22.9	58.9	46.6	24.4	11.8	24.2	18.3	24.2	13.7	24.8	22.7	0.0	28.3	24.3	18.6	34.9	20.9	32.7	15.6	60.4	24.6	25.2	31.0	17.2	25.9	18.9	0.0	34.3	38.9	26.9	30.1	24.6	29.7	19.2	39.1	32.3	0.0	34.9	59.5	0.0	43.3	17.5	31.2	40.1
KMT5C	"MGC2705, SUV420H2"	ENSG00000133247	"Lysine methyltransferase 5C"	Q86Y97	19	55339853-55348120	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 47.4;Cone photoreceptor cells: 47.1;Horizontal cells: 63.5;Rod photoreceptor cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.6;SCLC-21H: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052294	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052294: AB_2681788"	"unprognostic (4.02e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.77e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.05e-8)"	"unprognostic (7.39e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.39e-2)"	5.0	5.6	8.5	7.3	15.7	13.4	5.4	20.0	10.7	5.1	7.5	11.2	4.9	11.9	7.0	5.4	4.6	11.0	7.4	4.2	11.2	4.5	5.1	4.4	5.5	4.6	17.1	5.3	6.1	8.5	6.2	11.7	6.5	9.6	6.6	3.8	6.3	7.7	6.3	6.6	13.5	8.5	3.6	6.2	6.2	9.8	7.0	14.7	10.1	5.1	2.3	3.5	6.3	4.6	0.3	0.8	0.9	0.6	1.1	0.8	0.3	5.0	3.5	3.3	2.8	0.7	0.9	9.3	1.4	0.6	0.5	1.3	2.2	4.3	5.0	1.8	1.1	0.2	2.8	2.1	1.8	0.6	4.5	16.6	4.0	2.5	2.2	1.2	2.3	4.8	0.8	2.5	1.7	0.9	0.7	1.1	5.5	9.8	2.8	0.6	5.8	6.6	5.2	6.0	3.0	5.2	9.8	3.9	4.9	0.8	1.3	16.2	6.9	0.7	3.7	2.0	1.9	4.2	2.9	1.2	1.6	4.0	0.5	1.0	8.3	4.1	3.2	0.8	5.6	2.2	0.3	0.6	0.3	0.7	0.4	0.0	0.1	0.5	0.7	0.6	0.3	0.3	0.8	0.9	1.1	0.0	0.8	0.2	0.3	8.5	15.7	20.0	10.7	11.2	4.5	17.1	5.3	9.6	14.7	6.0	5.5	1.9	11.9	0.0	47.4	0.0	10.2	6.7	5.7	3.5	47.1	25.7	1.7	5.8	1.6	2.2	8.4	23.3	2.6	16.4	3.1	9.2	2.3	1.0	8.3	63.5	7.0	4.9	3.1	1.5	6.9	4.9	0.0	1.0	14.9	28.9	6.1	15.3	6.0	2.1	46.0	6.5	0.0	8.4	11.1	0.0	16.6	9.6	13.3	9.8
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401545	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 57.2;smooth muscle: 41.1"	"Cell type enhanced"	"Detected in some"	15	"Basal keratinocytes: 24.8;Early spermatids: 36.8;Muller glia cells: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	47	"memory B-cell: 4.9;naive B-cell: 2.8;plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	58	"B-cells: 4.9;dendritic cells: 7.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 38.5;ASC TERT1: 31.0;BJ: 23.4;fHDF/TERT166: 43.5;HBF TERT88: 28.1;U-2197: 69.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035740	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favorable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	1.9	19.5	13.4	3.8	12.5	0.2	1.4	0.3	16.0	17.2	7.7	6.7	7.3	2.7	57.2	7.8	17.4	1.9	15.1	3.2	9.8	1.1	21.4	1.2	15.3	2.9	1.0	6.4	2.4	1.7	0.1	4.3	3.3	0.2	17.6	4.9	0.9	10.6	21.5	0.4	7.4	4.5	41.1	0.8	3.2	3.1	3.1	4.6	0.8	1.5	7.7	7.7	9.4	8.6	4.9	7.8	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.9	0.0	38.5	31.0	0.0	23.4	15.9	8.6	15.1	0.0	0.2	0.1	0.0	43.5	7.1	0.0	0.3	0.1	28.1	0.0	4.3	0.0	0.0	0.0	0.3	0.0	0.0	7.3	0.0	17.3	0.5	10.7	0.0	0.0	0.0	1.7	5.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.1	0.0	10.5	0.0	0.6	0.0	0.0	0.1	0.5	2.3	0.0	1.3	0.1	3.9	3.7	69.7	12.2	0.9	0.0	0.0	10.0	0.0	11.5	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.3	13.4	12.5	0.3	16.0	9.8	1.1	1.0	6.4	0.2	4.6	0.0	2.2	3.4	0.4	24.8	0.2	0.6	0.0	0.0	4.5	1.8	0.0	0.6	0.0	0.4	36.8	0.0	0.0	0.0	0.0	1.0	9.6	0.2	3.5	0.0	0.4	0.0	0.0	0.0	0.0	6.8	0.3	0.6	6.8	0.0	0.0	14.0	0.4	0.0	0.4	0.0	0.8	0.0	0.4	0.5	0.4	5.9	0.0	0.0	0.0	0.0
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300215	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239"	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	11.8	13.2	11.9	25.4	15.7	23.9	14.0	28.9	16.7	15.6	14.2	18.5	17.0	10.6	19.0	13.9	17.8	13.6	15.8	11.7	12.8	11.5	14.4	10.5	12.3	19.4	12.9	11.7	16.6	27.1	24.6	19.3	16.0	13.4	14.2	14.3	13.8	13.5	18.7	20.6	16.1	14.5	15.6	13.2	16.1	13.1	28.1	16.1	27.3	20.1	10.6	22.7	13.4	20.2	10.2	8.9	18.7	10.8	10.9	7.8	2.9	9.9	12.8	13.3	11.5	6.6	8.5	0.4	9.0	9.0	12.7	11.8	2.8	8.3	20.5	10.2	12.4	11.7	8.5	21.2	20.0	15.4	34.7	12.8	9.1	14.5	0.1	10.9	19.6	10.8	8.0	12.1	15.0	14.1	9.0	18.4	13.0	12.4	7.2	12.7	20.8	13.6	6.3	14.5	6.7	11.3	15.1	1.7	6.3	8.2	12.1	16.3	11.2	23.4	10.2	7.0	12.9	10.2	16.3	13.5	8.8	12.9	5.6	11.1	8.5	7.4	14.7	5.1	9.6	9.4	10.7	9.1	9.4	7.5	6.1	6.3	8.5	6.3	5.0	6.7	10.2	7.8	6.3	18.7	10.9	10.8	8.9	5.7	2.9	11.9	15.7	28.9	16.7	12.8	11.5	12.9	11.7	13.4	16.1	20.8	26.1	42.4	26.2	15.0	91.7	37.5	33.1	13.4	36.4	52.4	141.4	34.8	14.9	22.8	25.5	31.5	21.9	0.0	18.5	20.4	23.3	24.0	39.4	16.3	24.2	84.2	40.3	31.3	29.2	33.9	47.2	39.1	15.1	50.5	19.4	35.7	20.1	24.6	31.1	13.9	100.0	51.8	19.6	63.2	47.7	18.1	29.6	51.1	21.5	23.5
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871424-1982207	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 17.3;Ciliated cells: 13.4;Club cells: 14.8;Collecting duct cells: 12.2;Hofbauer cells: 11.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm		No	No			Nucleoplasm		"CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	8.7	7.6	17.6	11.5	16.2	35.1	8.5	20.6	18.2	7.0	14.8	12.4	6.3	14.0	9.5	7.4	12.7	6.8	6.9	11.9	15.1	10.9	8.4	7.5	11.1	18.8	14.7	16.1	7.0	11.7	10.7	11.8	9.8	14.6	8.7	17.7	9.4	10.2	7.4	11.8	12.1	14.6	10.5	15.3	13.5	11.0	26.3	13.4	46.7	13.8	5.5	17.7	8.6	9.4	4.9	3.9	4.1	1.8	2.7	4.3	0.6	27.7	14.0	42.3	18.5	4.6	6.8	12.3	22.4	19.9	27.5	30.8	12.4	33.0	29.9	7.7	18.5	36.0	12.1	27.3	18.5	47.3	14.3	11.3	35.6	19.4	7.3	5.8	21.8	18.7	2.6	4.7	24.1	23.2	15.2	21.6	30.2	19.3	31.4	22.5	10.9	58.1	22.9	17.8	14.1	16.2	33.2	27.6	10.3	11.3	13.2	26.3	21.0	18.4	6.9	8.4	19.2	16.3	14.6	16.7	27.5	20.5	17.4	45.1	14.7	15.5	27.1	16.5	21.6	25.5	2.1	1.7	1.7	2.9	1.8	3.2	1.8	3.2	3.2	1.5	4.9	2.8	2.3	4.1	2.7	1.4	3.9	4.3	0.6	17.6	16.2	20.6	18.2	15.1	10.9	14.7	16.1	14.6	13.4	11.9	17.3	0.0	0.0	0.0	0.0	0.0	0.0	13.4	14.8	12.2	0.0	10.0	3.3	10.2	0.0	0.0	0.0	0.0	6.1	7.3	0.0	0.0	2.3	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	10.0	0.0	0.0	10.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
NSD3	"FLJ20353, KMT3F, WHISTLE, WHSC1L1"	ENSG00000147548	"Nuclear receptor binding SET domain protein 3"	Q9BZ95	8	38269697-38382272	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 85.7;Extravillous trophoblasts: 142.9;monocytes: 86.6;Syncytiotrophoblasts: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005659, CAB013721, HPA018893"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833"	"unprognostic (6.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.60e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.60e-2)"	19.2	11.3	31.1	15.8	31.4	36.3	20.1	51.5	37.7	18.5	15.5	16.7	14.0	16.2	16.0	12.5	17.0	16.8	17.0	12.7	24.4	16.6	14.2	11.2	17.9	22.3	25.0	26.8	26.5	16.3	21.0	24.2	22.5	21.9	16.4	18.7	12.3	18.3	17.9	12.3	16.2	17.7	16.0	15.3	17.2	19.7	9.3	25.6	16.7	19.2	6.9	20.4	19.6	23.3	26.7	5.6	26.2	5.1	8.6	18.0	2.9	24.1	13.9	23.9	16.1	16.8	19.3	17.7	20.3	22.4	17.6	20.5	7.4	13.4	28.8	18.7	13.8	17.1	14.6	18.9	16.2	25.2	11.4	11.1	36.7	11.2	8.6	17.2	16.1	13.3	10.3	16.5	15.9	32.4	16.5	20.1	31.9	26.0	19.2	16.7	8.7	47.1	13.7	16.2	18.8	6.6	21.6	26.1	9.1	12.5	18.7	13.5	18.2	16.5	14.5	14.1	16.0	18.2	12.3	19.2	18.3	19.0	27.2	11.9	17.1	20.4	27.8	15.5	16.3	13.2	13.9	5.1	9.1	8.0	2.4	5.3	16.5	12.0	7.1	4.1	26.7	15.0	6.3	26.2	8.6	1.5	5.6	18.0	2.9	31.1	31.4	51.5	37.7	24.4	16.6	25.0	26.8	21.9	25.6	62.5	52.3	0.0	0.0	0.0	0.0	0.0	0.0	62.9	55.7	48.8	0.0	85.7	19.9	60.6	0.0	0.0	0.0	0.0	53.3	142.9	0.0	0.0	8.1	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	86.6	0.0	0.0	50.3	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	109.4	0.0	0.0	0.0
OGDH	E1k	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.3"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		No	No		53000	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	18.9	20.8	12.3	14.5	18.5	8.7	11.0	14.3	23.7	10.1	19.4	15.9	13.5	29.0	16.2	11.1	19.5	11.1	11.8	73.9	11.3	12.8	28.8	14.8	13.0	11.1	14.2	11.7	9.8	13.0	25.5	11.0	14.5	22.2	12.3	13.3	22.3	23.7	15.9	99.3	15.6	35.5	16.4	10.1	12.1	14.9	11.3	11.0	11.3	17.8	39.8	15.8	13.0	10.8	7.2	13.4	7.5	20.4	11.2	25.7	11.6	10.8	22.8	13.7	20.8	21.2	23.3	13.3	17.0	16.6	19.3	16.9	20.7	22.5	47.8	20.2	24.7	39.0	33.8	27.0	25.4	18.9	27.9	7.1	14.5	46.1	10.2	10.8	17.9	16.3	21.6	19.3	27.4	19.7	14.2	26.2	16.0	16.7	14.3	20.4	15.3	17.7	10.3	12.6	30.2	25.7	17.0	9.6	53.6	22.2	32.4	23.4	11.2	24.5	34.1	10.6	25.9	20.2	18.0	20.6	13.9	12.6	24.2	19.6	13.0	24.9	26.4	25.3	20.3	25.3	4.8	12.1	7.3	11.7	17.7	12.8	7.2	13.5	11.7	13.4	5.9	5.8	7.0	7.5	11.2	20.4	6.6	25.7	11.6	12.3	18.5	14.3	23.7	11.3	12.8	14.2	11.7	22.2	11.0	6.0	22.7	20.4	11.1	17.3	20.1	100.7	15.3	12.0	9.1	45.4	17.7	19.4	26.6	13.2	43.1	14.2	61.4	0.0	14.8	14.3	16.4	14.4	20.8	17.5	29.3	58.8	22.4	14.1	22.4	20.0	10.9	21.9	20.3	21.6	29.2	15.4	16.7	21.0	16.3	38.9	22.2	19.4	18.2	9.1	20.0	23.1	30.7	13.8	27.6	14.2
OGDHL	FLJ10851	ENSG00000197444	"Oxoglutarate dehydrogenase like"	Q9ULD0	10	49734643-49762379	"Citric acid cycle related proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 74.9;liver: 48.8"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 28.8;Collecting duct cells: 27.9;Cone photoreceptor cells: 29.5;Distal tubular cells: 77.9;Hepatocytes: 45.6;Horizontal cells: 28.6;Proximal tubular cells: 55.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 44.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"memory CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 13.7;RPTEC TERT1: 28.2;SH-SY5Y: 10.6;SK-BR-3: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043716, HPA052497"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA043716: , HPA052497: AB_2681853"	"unprognostic (9.05e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.60e-1)"	"prognostic favorable (1.21e-14)"	"unprognostic (3.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.38e-2)"	0.9	8.1	8.3	1.0	15.3	0.8	0.8	16.2	23.6	1.3	1.3	4.9	2.7	1.4	2.2	1.7	0.9	1.5	1.1	4.1	8.7	13.7	74.9	48.8	0.8	0.9	12.1	11.0	1.9	3.4	23.1	11.7	0.9	23.6	1.8	1.0	8.2	10.3	5.0	0.9	0.8	1.4	1.2	2.9	1.0	1.4	1.9	3.2	0.0	13.0	0.0	1.1	1.4	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.0	13.7	0.0	0.0	1.7	0.0	0.0	0.7	0.1	6.6	1.5	0.0	7.4	0.0	2.2	0.2	4.7	0.1	0.2	0.0	0.3	0.0	0.1	3.3	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.4	0.0	3.4	0.3	0.0	0.0	2.0	5.0	4.5	1.3	0.5	0.6	0.0	0.0	0.0	28.2	0.4	7.8	10.6	0.1	10.4	0.7	4.2	2.9	1.8	0.0	0.0	7.1	0.0	0.4	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	15.3	16.2	23.6	8.7	13.7	12.1	11.0	23.6	3.2	0.0	0.0	1.9	0.5	0.0	28.8	3.2	2.5	0.0	0.0	27.9	29.5	0.0	77.9	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	45.6	0.1	28.6	4.6	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.2	3.4	0.1	0.0	0.0	55.6	16.3	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.1
PIPOX	LPIPOX	ENSG00000179761	"Pipecolic acid and sarcosine oxidase"	Q9P0Z9	17	28950513-29057220	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"kidney: 33.5;liver: 114.3"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 183.0;Proximal tubular cells: 123.0"	"Group enriched"	"Detected in many"	13	"glioma: 15.5;liver cancer: 73.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"AF22: 12.5;Hep G2: 37.6;NTERA-2: 24.8;RH-30: 35.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA		390000				"unprognostic (8.02e-2)"	"unprognostic (3.50e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.45e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.22e-1)"	0.2	0.2	2.4	0.2	3.1	0.1	0.2	2.2	2.9	0.2	1.4	3.8	0.0	3.1	0.4	5.8	0.5	2.1	0.8	0.2	3.5	2.5	33.5	114.3	0.3	0.3	3.6	3.1	0.3	0.2	0.3	0.2	1.0	4.0	0.5	0.3	0.2	0.2	0.9	0.1	0.2	2.6	0.6	1.7	0.3	0.2	0.2	0.7	0.0	0.1	0.0	0.2	0.3	0.1	0.7	4.7	3.7	0.7	0.9	1.9	0.7	0.0	0.0	12.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.2	0.1	37.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.2	24.8	0.7	0.0	0.1	35.8	0.7	0.0	0.0	4.0	1.2	0.1	0.0	0.2	2.1	0.0	1.5	0.0	0.0	0.0	0.0	1.6	0.3	4.2	0.1	0.0	0.2	1.2	1.8	0.7	0.7	0.8	0.5	0.9	0.3	0.5	1.2	4.7	0.7	0.3	1.9	3.7	0.9	0.3	0.4	0.8	0.7	2.4	3.1	2.2	2.9	3.5	2.5	3.6	3.1	4.0	0.7	0.0	1.1	2.2	0.2	0.2	1.7	0.4	5.1	0.0	0.0	0.0	3.9	0.1	8.3	0.0	1.3	0.6	0.7	0.0	0.2	4.4	0.4	0.3	5.7	183.0	1.2	0.0	1.2	2.5	3.5	1.5	0.3	1.7	0.0	3.6	0.0	24.0	0.0	0.0	1.1	123.0	1.3	0.0	0.4	0.0	1.0	0.1	0.3	0.5	0.0	0.1
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 215.9;Sertoli cells: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2700000	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.43e-4)"	29.0	19.5	14.9	16.8	24.0	7.1	32.1	12.1	17.6	35.8	21.7	17.0	17.7	19.1	34.2	21.1	16.5	24.7	21.3	31.2	17.6	14.8	27.5	51.3	22.2	19.7	24.5	9.9	31.8	30.3	18.2	16.3	41.5	20.8	21.1	12.0	25.1	39.3	22.0	18.3	13.3	20.8	39.0	13.2	21.1	18.6	10.0	22.4	1.7	34.8	11.1	8.2	19.5	69.7	1.6	16.3	17.7	19.4	2.6	9.1	9.3	16.9	14.5	8.0	37.4	54.7	30.6	6.4	50.4	67.0	26.6	45.3	16.5	11.1	9.8	53.4	55.7	19.8	14.3	11.6	17.6	18.3	10.2	12.4	5.3	23.3	20.9	33.9	3.3	25.8	37.1	9.3	32.1	12.9	90.3	47.1	2.2	14.8	4.8	27.7	11.0	0.8	8.9	3.5	17.3	21.6	3.9	16.3	21.3	15.3	3.8	3.0	12.7	22.0	15.1	25.4	13.1	7.6	8.5	46.5	30.4	22.8	38.0	24.7	11.3	18.3	5.8	67.4	11.6	49.6	0.0	19.4	0.9	9.1	17.2	1.6	1.0	1.6	4.4	16.3	1.6	0.6	3.4	17.7	2.6	15.0	2.4	1.0	9.3	14.9	24.0	12.1	17.6	17.6	14.8	24.5	9.9	20.8	22.4	0.0	9.3	3.7	7.6	6.3	4.2	16.2	10.2	4.0	5.7	10.4	2.0	34.8	3.3	30.5	1.1	20.4	18.7	0.0	8.4	215.9	28.4	9.2	0.0	29.9	41.8	6.4	8.1	46.6	21.6	1.7	41.1	15.6	10.1	18.0	9.8	10.1	24.0	12.9	23.0	13.7	2.7	103.5	26.2	0.5	3.6	4.4	28.1	4.4	11.0	3.8
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.1"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 109.4;Pancreatic endocrine cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 82.6;hTERT-RPE1: 93.9;U-87 MG: 73.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoli, Cytosol"		"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavorable (7.64e-10)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.99e-11)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	36.7	14.1	11.2	18.0	12.1	0.7	28.5	7.9	13.5	8.8	25.2	5.1	8.3	21.6	14.8	7.5	12.0	8.0	22.3	16.6	12.5	8.2	16.4	73.1	9.3	3.0	10.7	4.8	17.7	14.4	13.9	7.8	41.0	13.0	11.1	16.1	7.2	7.7	11.3	4.8	3.2	24.7	24.2	19.4	3.2	13.6	6.3	10.9	6.1	47.6	3.5	3.0	21.8	28.7	0.0	0.0	1.5	0.3	0.0	0.0	1.9	16.4	11.8	3.7	1.2	13.5	14.5	9.4	58.5	17.9	31.9	60.2	0.9	1.7	0.0	11.4	9.9	14.6	3.5	4.3	50.3	82.6	0.0	6.8	4.1	11.5	8.2	34.7	0.0	0.0	25.4	7.2	27.6	13.5	93.9	44.0	0.0	5.4	0.2	56.3	6.0	0.0	0.0	2.3	0.0	5.1	0.0	2.4	0.0	13.4	0.8	1.8	0.0	46.6	5.0	4.9	18.1	13.6	0.5	55.2	39.5	12.0	12.5	34.9	17.9	2.5	0.0	73.6	0.0	7.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	11.2	12.1	7.9	13.5	12.5	8.2	10.7	4.8	13.0	10.9	14.9	10.7	0.5	5.9	6.3	14.5	10.6	61.1	12.0	13.6	26.2	33.4	6.8	8.3	62.8	0.4	21.2	46.1	0.0	45.9	109.4	34.5	8.1	0.0	50.8	4.7	0.0	19.0	18.4	1.5	1.3	12.0	2.7	13.5	1.0	18.3	65.1	83.0	31.5	4.6	6.9	22.4	19.4	38.1	8.0	16.3	4.8	15.7	0.7	21.3	5.4
PLOD3	LH3	ENSG00000106397	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3"	O60568	7	101205977-101218420	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Dioxygenase, Glycosyltransferase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 13.4;monocytes: 14.3;T-cells: 9.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 105.8;WM-115: 102.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001236	Uncertain				"Secreted - unknown location"	NA	NA		370000			"HPA001236: AB_1855474"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.91e-5)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.87e-2)"	23.9	16.1	11.9	19.5	24.0	14.6	35.4	7.2	19.2	17.8	20.0	31.2	16.6	22.7	22.9	15.1	11.0	17.4	16.7	22.1	14.8	11.6	20.2	54.1	21.0	18.2	36.3	8.9	16.1	23.2	18.5	16.5	33.1	22.4	14.4	14.2	11.1	11.3	19.6	8.8	14.0	23.2	23.2	29.0	20.4	16.7	10.1	30.6	5.1	16.8	6.0	6.9	17.3	42.6	2.6	13.4	2.8	14.3	2.5	9.2	5.3	10.1	9.2	3.8	25.8	18.4	13.3	7.9	18.7	21.0	19.2	13.9	14.8	13.2	0.8	21.1	32.3	14.8	12.4	7.7	11.0	4.9	5.5	3.5	1.0	11.1	14.4	25.4	4.6	8.7	14.3	10.5	11.2	8.9	18.2	17.0	0.7	9.8	105.8	12.9	29.0	0.4	10.9	8.1	17.5	14.0	3.2	5.2	15.7	6.5	3.0	2.9	17.5	11.6	17.0	41.7	10.7	3.2	15.9	14.8	29.1	14.2	35.2	22.9	5.9	10.8	0.6	17.2	11.1	102.0	0.0	10.8	2.8	9.2	14.3	8.1	2.6	6.8	6.1	10.4	1.8	3.2	3.4	1.0	2.5	14.3	13.4	4.3	5.3	11.9	24.0	7.2	19.2	14.8	11.6	36.3	8.9	22.4	30.6	20.8	8.3	9.0	8.8	7.9	5.1	12.3	17.8	12.0	7.9	24.4	13.7	16.7	1.7	35.7	0.4	23.6	35.9	0.0	27.6	62.3	31.0	7.5	19.6	16.6	45.4	7.9	15.5	27.0	21.6	1.5	24.2	16.4	59.1	20.8	16.2	10.8	29.4	28.1	13.8	10.5	5.9	19.4	17.6	7.2	12.6	4.3	15.8	8.6	21.1	4.2
SCCPDH	"CGI-49, NET11"	ENSG00000143653	"Saccharopine dehydrogenase (putative)"	Q8NBX0	1	246724047-246768137	"Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 95.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 1022.4;Spermatocytes: 461.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	17	"basophil: 95.3"	"Lineage enriched"	"Detected in all"	22	"granulocytes: 95.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 53.5"	"Low region specificity"	"Detected in all"							"HPA050775, HPA076030"	Enhanced		Approved	Vesicles		NA	NA		2100000	Vesicles		"HPA050775: AB_2681231, HPA076030: "	"unprognostic (4.25e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	14.1	25.8	15.7	6.4	17.5	13.4	11.3	11.3	20.5	10.9	11.7	24.7	8.5	15.1	12.0	8.5	4.8	14.4	9.7	15.8	15.6	19.8	23.0	67.3	9.3	7.3	26.1	15.0	10.6	12.7	15.0	12.7	14.1	21.7	18.1	12.2	7.3	7.4	16.7	23.9	10.7	15.3	10.8	62.1	5.1	12.4	65.1	17.5	8.5	18.2	7.3	4.8	25.0	13.2	1.4	2.3	95.3	3.2	4.2	3.0	2.1	13.1	12.8	9.4	5.6	11.3	14.2	0.1	10.3	14.4	17.4	14.6	7.8	37.0	7.0	13.5	11.8	9.7	4.3	7.9	3.0	17.9	9.7	2.9	11.8	11.7	15.6	10.6	22.9	10.2	9.5	1.4	11.8	1.2	16.5	18.6	14.7	14.7	0.0	17.3	3.1	23.8	29.1	14.1	7.1	10.2	20.1	12.1	0.0	53.5	30.9	10.7	12.0	13.9	0.6	9.1	5.2	10.4	23.9	12.1	8.1	7.2	19.6	26.5	34.7	11.9	4.1	13.8	31.3	10.6	95.3	3.2	5.5	2.5	2.8	3.0	1.4	0.7	2.1	1.3	1.1	1.0	3.0	0.8	4.2	1.8	2.3	0.5	2.1	15.7	17.5	11.3	20.5	15.6	19.8	26.1	15.0	21.7	17.5	6.0	11.5	8.0	36.7	26.8	29.6	33.1	50.9	52.2	17.0	144.8	17.7	28.0	26.6	57.2	1022.4	20.2	47.9	0.0	61.3	13.6	42.0	76.7	57.5	163.4	83.3	6.4	43.0	21.5	44.3	154.3	44.0	20.4	45.5	15.4	25.1	52.2	56.6	28.1	44.6	51.6	30.6	19.4	27.8	461.4	68.6	59.8	70.7	16.7	53.2	149.1
SEC11A	"SEC11L1, sid2895, SPC18, SPCS4A"	ENSG00000140612	"SEC11 homolog A, signal peptidase complex subunit"	P67812	15	84669538-84716716	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047533			Approved	"Nuclear membrane,Golgi apparatus"		NA	NA		7400000	"Nuclear membrane"	"Golgi apparatus"	"HPA047533: AB_2680078"	"unprognostic (8.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.19e-2)"	"prognostic favorable (1.94e-5)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (5.99e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.89e-2)"	65.5	43.6	18.7	23.3	17.3	36.4	42.6	11.2	15.5	44.4	38.5	23.0	38.8	20.7	41.8	57.9	40.3	27.3	33.2	30.8	18.7	18.4	56.5	68.2	44.7	41.1	24.7	12.6	55.7	70.9	21.2	41.7	46.0	18.4	44.4	28.0	28.5	43.5	36.2	51.9	23.3	33.3	39.7	31.5	38.4	29.5	28.2	19.7	33.2	74.6	39.3	32.1	49.8	37.8	29.1	44.3	32.6	48.4	34.3	45.9	46.3	23.7	51.3	37.9	58.6	48.1	60.0	29.1	38.0	44.3	31.2	37.4	54.9	59.0	11.8	25.0	46.7	36.9	51.9	52.5	31.9	34.0	29.0	38.8	34.5	58.5	51.6	41.7	25.9	39.1	41.3	40.1	21.5	34.9	50.9	44.1	15.5	34.2	31.8	42.1	55.7	10.6	56.4	40.3	36.1	22.1	13.3	49.0	38.5	70.2	66.7	18.6	41.8	31.6	35.4	85.5	59.4	34.5	60.3	30.0	31.7	23.8	27.0	46.2	31.2	59.2	16.7	34.4	45.7	24.7	20.7	43.8	24.1	28.4	47.3	28.5	29.1	35.4	30.4	43.8	26.6	30.2	30.9	32.6	34.3	48.4	44.3	45.9	46.3	18.7	17.3	11.2	15.5	18.7	18.4	24.7	12.6	18.4	19.7	83.4	82.6	129.4	146.5	95.1	26.0	57.2	214.0	68.3	101.2	122.1	21.6	264.5	202.2	211.7	36.2	236.3	103.8	23.3	215.7	493.0	216.8	157.8	217.7	143.3	324.9	19.1	151.1	167.6	353.0	67.9	277.3	291.4	150.1	267.9	172.8	64.3	169.6	103.7	156.3	255.0	33.2	168.1	121.7	176.8	142.9	104.8	255.7	159.2	214.9	195.4
SEC11C	"SEC11L3, SPC21, SPCS4C"	ENSG00000166562	"SEC11 homolog C, signal peptidase complex subunit"	Q9BY50	18	59139477-59158836	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 132.6"	"Cell type enhanced"	"Detected in all"	5	"Glandular cells: 405.9;Muller glia cells: 440.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 59.5;Karpas-707: 64.1;RPMI-8226: 129.8;U-266/70: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026816, HPA047533"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Nuclear membrane"	"Golgi apparatus"	"HPA026816: AB_10602089, HPA047533: AB_2680078"	"unprognostic (1.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.13e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.83e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.15e-1)"	5.9	18.4	30.1	18.6	29.7	11.3	16.0	14.9	25.2	12.2	18.7	24.4	27.8	27.5	9.1	58.0	10.7	9.2	11.1	7.2	27.7	33.9	19.0	66.8	13.0	22.0	41.8	21.3	7.0	96.8	14.6	46.6	8.1	27.1	48.8	16.4	10.0	132.6	34.1	4.3	7.9	21.1	6.6	51.3	23.6	28.4	6.4	25.3	7.3	35.9	8.6	23.4	18.9	5.9	33.6	50.0	10.6	17.6	17.3	34.4	32.6	8.8	10.7	5.8	9.0	3.6	0.6	7.4	8.0	6.9	9.9	6.0	7.5	4.8	20.3	12.7	4.8	7.3	9.5	9.1	6.0	5.7	59.5	12.5	6.5	7.4	22.9	10.8	21.5	9.9	2.0	14.4	6.1	16.6	2.1	3.2	8.7	7.5	64.1	3.5	10.4	8.8	8.6	5.9	14.7	6.6	8.0	5.7	129.8	6.4	7.4	27.1	10.8	4.8	19.5	27.1	3.3	8.8	15.8	2.6	12.0	5.0	4.2	9.6	65.4	48.1	19.9	12.0	14.6	14.7	10.6	13.1	9.4	25.9	15.5	33.1	33.6	27.3	25.2	13.5	17.4	14.3	19.5	2.0	17.3	17.6	50.0	34.4	32.6	30.1	29.7	14.9	25.2	27.7	33.9	41.8	21.3	27.1	25.3	26.8	96.0	46.9	40.1	29.0	63.6	51.8	132.5	95.0	89.9	57.6	47.1	59.9	74.6	117.2	35.1	52.2	73.8	23.3	229.6	80.5	24.9	405.9	46.2	201.1	102.0	47.7	325.7	35.6	28.2	14.8	11.5	58.2	243.0	32.5	93.2	440.4	146.8	74.8	21.5	86.0	65.5	6.5	40.9	97.2	84.1	39.6	125.2	74.3	75.9	57.4
SETD1A	"KIAA0339, KMT2F, Set1"	ENSG00000099381	"SET domain containing 1A"	O15047	16	30957294-30984664	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020646, HPA058376"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA020646: AB_1856752, HPA058376: AB_2683695"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.18e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.94e-1)"	11.0	10.5	10.0	12.4	10.2	25.6	10.3	23.0	14.5	11.1	12.1	14.1	7.6	10.2	15.3	6.7	9.4	11.2	9.7	7.6	8.8	6.7	9.3	10.5	9.0	12.6	9.3	9.8	15.3	14.8	15.6	12.9	11.3	9.5	10.9	5.7	13.5	12.7	10.5	15.2	12.3	11.4	11.7	8.0	14.5	10.3	22.3	10.0	15.5	12.7	5.4	14.1	10.6	9.9	2.0	2.6	2.5	1.4	1.3	1.6	0.9	6.5	12.6	8.7	10.1	5.0	3.5	9.4	7.4	5.5	6.3	5.4	10.7	6.7	17.5	8.2	6.8	6.6	8.6	7.7	7.5	5.2	9.3	30.4	8.1	21.8	12.0	4.8	13.8	13.9	6.0	5.9	8.9	5.7	5.1	4.8	10.3	16.3	9.9	3.4	13.7	16.3	14.0	12.4	4.7	8.4	24.8	8.6	11.0	4.0	7.2	9.4	9.6	9.9	8.2	5.5	5.0	8.5	11.2	6.6	9.6	9.3	6.1	7.7	15.1	18.2	17.1	7.7	12.0	7.2	0.0	0.8	2.5	1.2	1.4	1.6	0.2	1.0	0.8	0.6	2.0	0.7	1.5	0.5	1.3	0.4	2.6	0.4	0.9	10.0	10.2	23.0	14.5	8.8	6.7	9.3	9.8	9.5	10.0	3.0	8.6	7.6	4.7	14.0	7.7	3.2	10.2	2.7	3.4	7.0	5.9	4.0	0.0	3.5	2.6	9.8	4.6	0.0	3.6	3.1	6.1	4.3	3.5	7.7	5.7	12.7	9.9	9.2	3.5	2.2	9.2	3.2	8.5	2.8	6.9	5.6	4.5	6.2	11.0	2.2	5.3	6.5	5.3	12.9	19.8	11.3	2.4	7.5	5.7	3.9
SETD1B	"KIAA1076, KMT2G, Set1B"	ENSG00000139718	"SET domain containing 1B"	Q9UPS6	12	121804180-121832584	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021667, HPA059412"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021667: AB_1856753, HPA059412: AB_2684006"	"unprognostic (1.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	13.8	9.6	9.3	16.8	9.4	22.7	18.1	22.0	11.1	19.6	25.0	7.4	16.0	13.0	27.2	14.8	15.8	21.1	18.2	10.0	8.9	4.6	10.1	10.9	10.9	11.9	5.4	7.4	17.4	14.3	12.1	11.9	12.2	7.1	16.5	6.8	14.4	15.9	31.1	12.9	11.8	15.3	14.7	5.4	14.4	17.8	9.1	7.3	31.1	14.7	8.9	14.7	22.8	14.4	1.3	2.1	3.9	2.0	1.0	2.1	0.8	6.0	12.1	6.4	10.5	6.0	4.1	9.7	5.7	4.7	4.6	2.6	6.8	3.7	4.5	5.3	6.4	2.7	9.5	7.4	4.6	2.6	7.9	9.0	13.9	15.0	5.8	5.1	12.6	11.9	5.0	5.4	6.2	4.9	5.2	4.8	9.0	14.2	3.2	3.1	14.3	18.0	16.7	8.9	2.9	7.4	14.1	4.2	6.4	4.1	12.7	7.9	6.0	13.0	8.7	4.7	4.8	10.8	10.9	8.0	6.5	8.1	9.2	6.3	6.3	3.2	2.7	5.4	7.9	7.4	3.9	0.9	2.0	1.9	2.0	1.3	1.2	1.3	1.8	0.7	1.3	2.1	1.3	3.8	1.0	0.8	2.1	1.3	0.8	9.3	9.4	22.0	11.1	8.9	4.6	5.4	7.4	7.1	7.3	3.0	5.3	2.4	3.2	10.4	12.0	8.3	7.6	0.0	6.8	5.2	7.9	6.5	0.0	4.5	7.5	9.3	5.5	0.0	6.2	5.9	7.4	6.7	3.5	11.9	5.7	11.1	7.0	12.9	21.6	14.4	10.6	5.6	1.7	1.0	7.3	5.3	5.7	9.5	9.6	3.0	8.4	6.5	7.2	12.5	1.0	11.3	11.0	8.5	6.7	6.5
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2"	Q9BYW2	3	47016429-47163967	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favorable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	13.2	10.5	12.2	15.2	15.4	20.0	11.7	22.4	16.4	13.4	14.0	9.1	12.9	9.5	15.8	7.5	10.8	11.4	8.7	8.8	10.6	6.8	11.4	10.3	10.4	11.8	11.7	9.5	16.0	13.4	21.4	16.3	10.7	11.3	12.4	10.9	7.7	12.7	14.8	27.6	12.5	11.5	11.9	9.8	13.8	10.4	12.8	12.8	23.2	15.8	5.5	12.8	16.1	15.5	4.8	2.6	6.0	2.3	7.1	3.9	1.0	11.6	9.2	15.4	7.9	9.3	10.7	6.5	10.7	10.4	12.6	11.5	9.7	7.6	25.7	6.7	14.8	12.3	7.1	16.7	10.2	17.1	14.7	6.6	26.4	15.3	7.5	7.0	19.7	15.3	9.2	9.9	12.4	15.4	10.2	11.6	13.3	16.9	9.7	10.3	6.1	14.5	2.6	11.7	5.6	7.7	9.6	15.0	13.3	6.4	15.3	6.7	10.6	18.1	7.1	6.7	11.5	7.5	14.7	14.8	13.9	10.4	11.8	17.1	12.5	13.9	26.0	8.0	11.3	8.1	2.4	2.2	5.2	3.9	2.3	2.4	3.7	2.4	3.0	2.5	4.8	3.5	3.0	6.0	7.1	1.9	2.6	1.0	1.0	12.2	15.4	22.4	16.4	10.6	6.8	11.7	9.5	11.3	12.8	44.7	53.3	20.6	20.5	29.7	33.4	58.5	22.9	66.9	80.8	10.4	39.3	16.3	10.0	17.4	24.0	29.3	26.5	0.0	19.3	10.1	20.8	25.9	55.6	26.7	14.3	25.4	21.2	23.4	27.2	20.8	28.1	21.6	16.9	20.8	27.8	21.7	20.0	17.5	31.1	9.3	37.0	12.9	21.7	78.1	18.9	31.1	15.4	27.7	24.8	34.2
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing lysine methyltransferase 7"	Q8WTS6	4	139495941-139606699	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	26.1	13.2	12.0	9.6	12.3	5.7	26.3	10.2	16.2	27.9	17.7	17.9	11.0	4.8	23.8	12.0	18.3	13.8	16.9	25.2	13.0	10.0	7.2	30.7	12.1	6.9	18.0	10.1	13.3	13.8	26.8	9.3	12.0	15.4	22.8	10.2	12.4	13.7	13.9	56.4	14.2	9.9	33.3	19.0	11.8	17.7	10.6	16.5	2.9	10.3	15.2	9.9	24.2	30.1	2.3	6.8	1.8	5.6	0.5	5.6	1.6	9.0	11.7	4.5	2.6	26.5	22.9	9.9	21.5	22.4	11.0	9.3	6.9	12.4	21.1	8.5	36.2	7.6	4.6	14.9	17.0	17.9	10.4	10.5	2.9	15.3	0.2	13.1	10.1	4.5	19.8	19.9	17.5	18.7	14.0	13.9	9.0	1.7	32.9	14.0	15.1	6.6	1.5	2.2	13.3	7.7	6.2	15.5	12.1	10.7	8.3	17.4	5.8	14.3	21.3	5.1	4.5	8.4	9.2	22.5	19.5	13.9	23.2	17.8	28.4	27.2	13.4	22.5	10.2	9.3	1.0	5.6	0.5	0.6	3.2	4.1	1.8	1.8	1.8	6.8	2.3	0.8	0.5	1.8	0.5	4.8	3.5	5.6	1.6	12.0	12.3	10.2	16.2	13.0	10.0	18.0	10.1	15.4	16.5	6.0	13.1	3.4	10.9	15.2	6.6	35.4	17.8	4.0	6.8	8.7	11.8	21.9	0.0	20.5	0.9	24.7	1.8	23.3	18.1	14.4	19.2	35.1	2.3	64.4	18.3	7.9	1.2	36.8	29.7	3.5	21.3	18.3	10.1	7.2	11.2	13.3	21.5	0.0	26.5	3.9	12.6	19.4	21.0	3.2	1.9	19.3	38.6	5.0	9.9	14.2
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"U-698: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles		Yes	No			Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: AB_2683731"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	16.9	15.4	9.5	21.2	15.9	16.9	17.7	21.6	18.2	18.6	15.4	25.2	18.6	13.0	22.8	18.9	15.6	16.8	14.0	10.9	9.6	8.5	13.3	12.7	15.6	20.7	15.3	13.2	23.9	17.6	21.0	15.4	18.4	13.7	14.9	16.8	20.6	16.1	18.5	20.0	18.0	17.1	17.9	13.7	21.9	15.0	33.5	14.2	24.5	18.6	12.0	20.7	18.6	16.3	11.2	12.8	6.9	14.9	7.6	9.1	5.3	5.9	6.9	10.0	6.6	4.8	6.4	16.7	4.9	5.7	7.1	6.1	4.6	8.2	11.6	6.8	5.4	2.8	7.4	9.3	5.3	5.6	5.6	11.5	6.6	7.1	5.3	6.8	11.6	6.3	8.4	5.9	5.8	9.5	7.2	8.3	7.5	11.0	9.5	5.0	11.4	8.0	6.8	13.7	8.3	5.5	9.3	6.5	8.6	5.4	6.8	7.3	13.3	7.5	8.8	5.9	12.6	9.5	15.7	5.6	4.1	4.3	4.5	6.8	9.9	10.6	90.6	4.3	4.1	4.0	6.8	10.7	6.9	8.3	14.9	8.7	8.7	7.4	9.1	12.8	11.2	8.3	8.3	6.5	7.6	10.6	8.6	4.7	5.3	9.5	15.9	21.6	18.2	9.6	8.5	15.3	13.2	13.7	14.2	6.0	12.3	5.3	7.2	4.8	10.9	4.1	5.1	9.4	6.8	7.0	17.7	11.4	3.3	6.6	23.5	6.9	6.2	0.0	5.0	7.2	4.9	6.2	7.0	6.2	8.8	6.4	3.5	10.4	14.2	21.8	9.5	10.4	1.7	7.2	10.3	6.3	7.3	10.7	9.2	5.4	10.1	6.5	5.9	22.4	14.5	4.4	8.4	7.0	9.3	6.4
SETDB2	"C13orf4, CLLD8, CLLL8, KMT1F"	ENSG00000136169	"SET domain bifurcated 2"	Q96T68	13	49444374-49495003	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Chromatin regulator, Developmental protein, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012190, HPA071677"	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"CAB012190: AB_2186195, HPA071677: AB_2686430"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.74e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (7.95e-2)"	"prognostic favorable (1.92e-7)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	10.2	14.5	9.8	20.5	10.8	9.5	14.1	14.4	12.3	13.0	12.4	8.3	13.6	7.8	13.1	11.6	9.8	9.9	9.7	12.7	8.2	6.9	12.4	11.0	16.3	19.0	7.2	11.1	21.0	15.0	10.8	15.8	7.8	9.5	13.6	11.9	13.5	11.7	10.9	5.5	9.6	11.4	11.3	8.4	19.0	10.7	18.1	8.7	17.3	14.6	3.7	16.6	11.9	10.3	8.4	7.4	4.7	5.4	7.8	10.2	4.5	2.0	1.4	4.3	4.4	6.1	6.9	2.2	5.9	7.4	5.3	5.0	8.7	5.0	25.7	1.2	3.8	4.0	4.2	4.5	4.0	5.2	5.8	3.9	8.9	3.9	5.2	8.6	13.5	5.1	5.3	7.4	4.0	13.4	5.8	4.5	8.3	3.9	3.6	4.8	1.8	5.1	10.1	2.2	5.5	3.4	10.0	5.4	5.4	4.9	1.9	2.2	2.6	2.6	3.7	12.6	3.9	3.1	11.8	2.7	5.1	1.8	6.8	2.4	4.3	6.0	13.6	1.6	11.0	2.3	4.1	4.1	4.7	6.9	5.4	5.8	8.4	7.1	7.1	7.4	8.1	10.2	7.6	1.4	7.8	4.3	5.2	9.4	4.5	9.8	10.8	14.4	12.3	8.2	6.9	7.2	11.1	9.5	8.7	26.8	14.1	32.7	5.3	6.2	12.6	22.4	10.2	13.4	10.3	5.2	25.5	4.8	8.3	3.3	14.7	8.2	6.9	0.0	3.8	2.9	5.1	3.0	5.8	5.9	15.9	12.7	11.1	5.5	19.0	11.1	9.2	17.4	13.5	10.0	6.2	10.8	3.1	2.9	7.8	3.4	29.6	0.0	5.2	18.2	11.8	5.3	2.4	19.1	8.5	2.0
SETMAR	metnase	ENSG00000170364	"SET domain and mariner transposase fusion gene"	Q53H47	3	4303304-4317567	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA057999			Supported	Nucleoli		NA	NA			Nucleoli		"HPA057999: AB_2683574"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.61e-6)"	"unprognostic (5.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-3)"	14.1	6.2	7.3	7.2	9.2	3.7	14.2	6.9	8.5	12.5	6.5	6.2	5.2	4.3	19.4	7.6	7.2	12.5	8.2	6.3	6.6	4.3	10.1	5.3	5.1	6.5	9.1	8.7	19.4	9.8	5.7	7.4	5.6	6.5	13.9	6.9	5.7	11.9	10.0	7.7	7.3	5.7	16.8	7.2	5.0	6.0	7.3	10.8	13.1	11.5	8.3	4.4	11.3	13.3	3.8	1.6	1.9	3.3	0.5	5.3	1.5	3.0	2.7	8.2	1.7	19.7	6.5	8.3	3.3	1.0	3.3	3.1	2.8	2.3	8.0	3.5	1.8	6.0	2.6	7.2	5.0	3.6	5.4	6.2	10.0	4.9	4.5	2.3	4.7	4.2	7.7	3.9	2.4	0.8	3.0	4.8	9.1	6.6	3.0	5.1	4.1	7.0	3.0	8.0	1.9	4.7	8.3	8.1	3.3	3.1	4.2	6.5	9.6	4.0	5.0	4.3	5.4	4.8	2.7	3.1	4.9	6.9	4.1	4.3	4.0	9.5	19.8	1.8	5.4	4.1	1.9	1.1	1.3	2.3	3.3	2.0	2.9	2.7	2.9	1.0	3.8	4.5	5.3	0.2	0.5	1.9	1.6	1.7	1.5	7.3	9.2	6.9	8.5	6.6	4.3	9.1	8.7	6.5	10.8	0.0	5.3	2.7	7.6	2.2	5.2	5.9	5.1	9.4	13.6	0.0	0.0	20.4	11.6	10.1	0.6	6.8	2.3	0.0	11.6	12.2	7.4	3.2	1.1	2.5	5.2	0.0	3.5	3.7	1.0	0.9	8.9	1.8	0.0	4.6	2.6	4.1	6.6	5.1	12.4	4.3	2.8	6.5	5.7	4.6	5.1	0.5	13.6	1.3	5.6	3.1
SHMT2	SHMT	ENSG00000182199	"Serine hydroxymethyltransferase 2"	P34897	12	57229327-57234935	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 103.1"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 158.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 212.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020543, HPA020549"	Enhanced		Supported	Microtubules,Mitochondria		NA	NA		160000	Mitochondria	Microtubules	"HPA020543: AB_1856833, HPA020549: AB_1856834"	"prognostic unfavorable (8.37e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.84e-8)"	"unprognostic (3.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.74e-2)"	13.0	13.5	5.9	15.0	7.1	12.6	9.5	9.6	9.5	10.5	11.5	6.1	5.0	13.4	10.2	8.5	22.1	8.6	10.3	11.0	6.5	5.4	15.5	103.1	11.8	18.7	8.7	4.6	17.9	38.9	4.5	8.1	16.8	6.5	10.3	9.4	7.1	44.6	5.7	16.5	13.7	11.5	9.9	7.6	23.5	13.4	5.4	6.3	26.1	13.2	19.0	25.6	11.2	13.8	33.6	14.5	6.5	11.7	9.7	48.7	12.3	25.1	11.7	11.8	31.2	9.3	14.3	23.4	13.6	22.2	18.3	16.8	16.7	12.2	46.6	22.6	16.8	7.6	16.1	21.3	22.2	9.9	26.0	19.0	19.2	7.2	11.8	68.7	31.7	17.0	18.3	32.2	14.7	49.2	16.6	18.1	24.8	20.0	44.3	13.8	16.5	25.2	17.4	10.1	10.1	19.0	17.0	212.4	43.1	9.1	11.6	25.3	12.1	7.1	16.8	49.3	4.5	22.8	39.0	11.4	7.4	15.1	9.6	18.5	59.5	32.5	39.5	16.0	29.6	13.3	6.5	9.8	5.9	6.9	11.7	8.0	33.6	12.1	7.4	14.5	32.4	5.3	5.4	0.5	9.7	7.5	4.8	48.7	12.3	5.9	7.1	9.6	9.5	6.5	5.4	8.7	4.6	6.5	6.3	8.9	13.1	58.9	19.1	30.8	6.2	7.5	20.4	9.4	12.5	3.5	0.0	53.0	11.6	41.7	0.4	13.5	11.0	46.7	41.3	42.8	21.6	14.9	28.8	158.5	43.3	7.9	9.2	20.3	38.1	0.2	16.7	22.7	37.1	27.1	21.6	42.4	40.1	21.0	15.2	48.7	4.9	6.5	22.6	2.1	7.2	28.4	31.2	26.2	37.7	17.6
SMYD3	"KMT3E, ZMYND1, ZNFN3A1"	ENSG00000185420	"SET and MYND domain containing 3"	Q9H7B4	1	245749342-246507312	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 108.5;Late spermatids: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 95.1;K-562: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012229, HPA045821, HPA054352"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458"	"unprognostic (7.00e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.78e-5)"	"unprognostic (9.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.58e-1)"	6.0	12.0	9.9	9.7	16.2	7.6	10.6	25.9	14.7	8.9	6.5	6.4	3.7	4.5	8.7	21.8	6.1	10.0	7.7	5.8	10.3	12.0	8.9	5.5	9.2	6.3	12.0	10.2	8.0	7.2	6.7	11.9	4.6	15.3	6.8	8.3	9.5	5.3	5.9	9.5	6.7	5.2	7.6	6.8	5.3	6.1	10.5	8.1	7.5	18.8	3.6	9.3	8.3	6.6	11.3	5.9	8.3	3.4	19.4	12.9	8.7	4.7	2.9	4.2	3.6	4.8	6.6	4.2	6.7	5.0	7.9	17.8	3.7	5.5	7.7	5.4	6.2	4.9	3.1	3.8	7.5	26.5	4.0	3.9	4.5	4.3	4.5	9.0	4.6	95.1	17.7	1.8	10.4	6.7	6.0	5.4	5.5	35.9	2.7	7.7	1.6	8.7	8.8	3.7	6.6	4.7	8.1	5.1	11.2	5.7	6.9	10.0	4.8	3.1	0.4	6.1	4.7	3.9	7.8	4.1	3.8	2.6	2.7	7.9	13.6	3.7	4.0	7.3	6.3	4.4	8.1	3.4	8.3	10.5	3.0	10.8	11.3	11.1	12.8	5.9	11.1	12.3	12.9	2.4	19.4	3.3	3.8	11.8	8.7	9.9	16.2	25.9	14.7	10.3	12.0	12.0	10.2	15.3	8.1	6.0	27.8	5.3	13.2	10.9	5.8	7.7	2.5	44.2	13.6	12.2	21.6	7.8	13.3	20.6	46.2	11.7	4.2	0.0	28.1	33.5	15.4	5.4	108.5	4.2	10.3	9.5	24.1	9.2	3.8	74.1	10.3	6.0	11.8	1.8	8.3	9.1	16.5	2.9	16.3	14.6	13.9	0.0	15.1	17.3	24.7	10.0	6.1	13.6	9.2	6.4
SPCS1	"HSPC033, SPC1, SPC12, YJR010C-A"	ENSG00000114902	"Signal peptidase complex subunit 1"	Q9Y6A9	3	52704955-52711146	"Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046091, HPA055273"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA046091: AB_10959614, HPA055273: AB_2682768"	"unprognostic (5.47e-2)"	"unprognostic (4.04e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (5.93e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.09e-2)"	31.0	53.4	39.7	28.5	41.5	27.5	42.2	24.2	55.3	39.1	46.3	40.8	46.3	47.8	34.9	53.2	39.1	33.9	35.6	39.4	38.0	47.0	62.3	98.7	37.1	68.9	47.2	38.1	34.7	112.1	30.5	48.8	50.9	41.7	41.0	41.6	38.4	87.7	57.8	43.2	34.3	53.4	34.2	48.3	37.4	45.7	57.1	25.5	42.6	55.2	38.3	52.0	36.6	30.2	40.2	123.4	48.5	27.8	22.2	34.1	43.1	21.5	20.5	19.5	25.2	31.5	25.7	32.5	30.0	27.5	27.2	24.5	21.4	31.6	23.1	13.2	27.1	26.0	20.8	19.7	28.0	26.5	30.8	23.7	27.3	34.0	29.8	35.6	37.8	45.2	21.0	36.8	30.0	32.7	22.3	22.0	29.0	23.2	73.4	27.7	20.9	29.9	38.4	37.1	53.1	42.6	12.2	18.2	116.3	40.0	26.6	14.1	31.8	29.5	31.7	39.8	18.0	35.4	43.4	20.8	24.6	23.1	44.0	35.3	81.0	120.8	32.6	38.1	41.8	32.0	45.3	26.0	48.5	27.8	26.0	32.8	40.2	34.1	30.5	28.4	29.0	32.2	32.8	19.8	22.2	27.8	123.4	33.9	43.1	39.7	41.5	24.2	55.3	38.0	47.0	47.2	38.1	41.7	25.5	59.6	94.5	189.7	185.2	139.0	485.2	136.5	219.1	186.0	126.3	294.8	111.9	309.5	306.7	288.1	445.8	151.7	198.8	93.5	296.3	331.3	163.9	238.4	205.7	300.1	274.6	96.9	161.0	125.8	194.0	878.2	200.2	191.2	361.0	334.6	203.8	220.7	242.0	238.9	180.4	563.8	195.8	161.7	195.7	623.3	495.0	161.2	293.7	203.7	226.0	258.6
SPCS2	KIAA0102	ENSG00000118363	"Signal peptidase complex subunit 2"	Q15005	11	74949247-74979031	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA013386	Approved		Approved	Nucleoplasm		NA	NA		220000	Nucleoplasm		"HPA013386: AB_1857426"	"unprognostic (2.43e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (7.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.04e-3)"	"unprognostic (9.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.62e-2)"	21.8	32.8	29.1	25.8	29.2	13.4	28.7	20.0	26.8	36.5	30.4	26.8	49.5	23.2	32.3	61.6	23.3	25.8	21.4	25.2	29.8	27.5	30.0	46.5	24.0	25.3	33.4	33.5	24.0	75.5	41.6	26.7	28.5	32.9	29.2	31.1	18.6	55.9	34.9	26.4	17.2	24.0	24.8	33.4	30.1	26.5	24.2	27.6	20.3	43.9	14.9	38.7	23.8	21.4	78.2	89.7	86.4	45.9	47.9	65.4	71.8	22.3	26.3	35.2	31.5	31.0	20.9	19.2	32.1	31.4	29.6	26.0	51.7	50.8	36.4	40.7	27.1	35.4	41.3	30.4	23.5	37.0	30.0	22.3	36.9	32.0	42.6	35.3	39.1	26.0	18.5	30.7	24.9	41.0	26.1	28.3	26.9	42.4	95.0	26.8	34.0	27.8	25.0	21.5	88.9	25.1	34.7	54.2	82.5	34.1	37.4	28.6	28.7	32.0	43.1	105.2	25.5	41.7	30.0	22.8	33.8	21.0	35.0	28.3	40.6	41.0	67.6	13.9	27.8	34.1	86.4	45.9	41.3	58.3	44.4	65.4	78.2	54.0	55.9	43.4	62.1	41.4	49.6	29.6	47.9	38.2	89.7	50.9	71.8	29.1	29.2	20.0	26.8	29.8	27.5	33.4	33.5	32.9	27.6	80.4	121.2	168.1	276.8	270.4	92.5	52.0	203.8	105.7	150.2	226.8	49.1	294.6	160.8	248.0	23.5	169.0	110.2	186.9	251.0	262.7	270.0	340.7	151.3	327.2	251.3	90.6	120.3	149.8	135.4	21.2	222.9	194.9	494.3	215.6	135.9	198.0	231.8	129.8	183.9	236.3	72.2	168.1	200.5	94.2	127.2	200.6	388.7	197.1	133.3	256.7
SPCS3	"FLJ22649, PRO3567, SPC22/23, SPC3, YLR066W"	ENSG00000129128	"Signal peptidase complex subunit 3"	P61009	4	176319964-176332245	"Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 88.1"					"Low region specificity"	"Detected in all"			HPA053180	Approved					NA	NA					"HPA053180: AB_2682071"	"unprognostic (4.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.20e-3)"	"prognostic favorable (8.89e-6)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.44e-1)"	20.3	14.2	15.5	24.5	15.8	29.3	30.0	18.3	24.9	26.2	25.3	12.6	40.9	17.3	23.5	27.4	18.2	19.2	20.0	24.4	14.1	14.5	18.1	41.3	25.4	38.2	18.9	17.5	15.8	85.0	21.2	24.9	26.3	14.6	17.6	19.8	11.0	52.4	37.4	17.4	16.2	18.6	26.4	21.2	29.5	24.5	8.3	12.9	19.1	32.5	16.1	23.8	22.4	19.5	8.0	17.1	26.2	14.6	13.0	16.3	12.8	14.6	4.9	13.7	11.2	19.6	34.8	14.5	29.0	27.9	17.0	14.7	5.3	32.4	28.3	6.0	16.7	8.9	10.2	12.9	21.4	25.9	19.0	5.7	24.4	8.0	12.1	20.0	36.5	21.6	21.0	23.6	15.0	14.6	19.1	25.0	13.8	15.7	88.1	23.3	8.9	22.2	13.9	9.3	10.4	4.9	11.0	21.3	24.6	20.9	10.7	10.9	10.0	30.3	22.7	13.3	12.4	7.3	17.1	23.2	12.6	12.6	11.2	13.2	40.9	12.1	35.6	26.8	18.5	17.3	26.2	12.2	10.3	12.3	14.6	16.3	8.0	11.5	11.1	9.2	5.3	9.7	12.0	12.2	13.0	11.6	17.1	8.9	12.8	15.5	15.8	18.3	24.9	14.1	14.5	18.9	17.5	14.6	12.9	50.6	81.3	47.6	49.0	50.8	32.2	67.8	40.8	42.8	54.6	27.9	25.5	58.7	18.3	68.9	48.1	87.5	44.5	116.8	117.4	151.8	62.7	93.0	89.0	104.2	140.2	22.3	43.0	92.1	105.2	14.2	20.8	125.0	104.6	64.9	66.2	31.5	141.6	34.5	15.9	52.2	28.5	12.9	51.2	75.3	39.6	57.0	154.2	63.7	42.2	96.6
SUV39H1	"KMT1A, SUV39H"	ENSG00000101945	"Suppressor of variegation 3-9 homolog 1"	O43463	X	48695554-48709012	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Host-virus interaction, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.92e-2)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.51e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.91e-7)"	"unprognostic (2.29e-3)"	"unprognostic (6.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (5.67e-2)"	5.7	3.3	6.5	6.4	7.6	18.0	4.9	8.7	12.5	7.0	5.1	9.3	6.0	5.1	5.7	20.7	7.3	5.3	3.4	6.0	6.0	8.3	5.0	9.2	4.6	10.8	8.8	6.9	6.5	4.4	3.6	4.7	9.3	6.7	4.5	5.4	8.3	6.5	5.4	6.9	7.0	6.0	4.7	6.2	9.5	5.2	6.7	5.9	21.2	3.9	6.4	10.7	4.8	3.5	5.8	2.8	7.1	6.4	10.7	11.7	6.8	14.8	18.2	7.2	7.6	1.8	2.2	14.7	7.2	5.5	14.1	11.5	11.1	10.0	16.5	4.4	5.2	14.3	10.5	17.8	10.2	8.5	12.5	18.2	6.5	16.9	9.0	1.1	15.9	3.6	2.0	2.0	12.4	6.4	2.3	10.0	10.8	16.3	11.6	7.6	17.2	13.6	16.6	8.5	7.3	17.7	10.0	13.3	17.4	4.6	8.3	9.5	6.2	9.8	9.5	5.2	8.4	14.1	13.3	5.3	8.7	15.0	12.0	12.1	8.0	12.0	13.9	6.5	22.9	9.5	4.5	3.0	7.1	9.8	4.4	7.2	5.3	6.5	10.3	2.4	5.8	8.1	7.7	2.1	10.7	6.4	2.8	11.7	6.8	6.5	7.6	8.7	12.5	6.0	8.3	8.8	6.9	6.7	5.9	6.0	0.0	7.7	0.8	1.5	4.9	2.2	0.0	4.0	1.2	1.8	0.0	4.4	3.3	1.8	0.1	0.9	1.6	0.0	2.5	24.4	1.4	0.4	1.1	5.6	4.5	0.0	2.9	1.8	1.9	0.0	1.1	2.5	5.0	3.6	1.5	0.6	1.8	1.7	1.4	1.4	3.5	0.0	1.2	1.5	0.8	1.0	5.1	4.5	1.6	0.3
SUV39H2	"FLJ23414, KMT1B"	ENSG00000152455	"Suppressor of variegation 3-9 homolog 2"	Q9H5I1	10	14878820-14904315	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.8"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 302.5;Late spermatids: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045901, HPA057554"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA045901: AB_10960702, HPA057554: AB_2683466"	"prognostic unfavorable (5.55e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.39e-1)"	3.0	2.9	4.7	3.4	7.4	4.9	5.2	20.0	8.6	3.1	3.8	1.6	2.1	3.2	3.8	2.3	4.0	3.0	3.2	2.4	5.4	2.8	3.5	3.8	2.7	3.6	3.3	4.4	4.2	2.4	2.4	6.3	5.1	3.3	3.9	4.7	1.6	2.4	3.6	2.4	3.3	2.9	3.7	3.0	3.4	2.7	41.8	4.4	10.3	2.8	4.9	4.0	3.3	2.8	0.8	3.1	0.5	1.8	5.6	4.0	0.8	13.7	13.1	22.0	12.5	4.1	5.0	8.6	7.5	4.6	14.0	19.9	19.6	7.9	11.1	6.8	4.5	12.3	9.7	16.3	9.1	17.3	11.3	10.8	16.7	9.3	12.1	2.4	7.5	8.0	2.4	3.2	14.2	4.4	3.1	9.6	18.9	21.5	7.5	10.3	13.5	14.8	2.1	13.6	12.6	3.5	18.4	14.5	8.9	5.9	6.6	7.3	8.1	11.7	7.3	6.3	13.5	12.9	6.5	5.6	10.1	16.3	12.3	11.9	4.3	16.1	25.5	6.2	8.2	6.5	0.5	0.4	0.3	2.8	1.8	4.0	0.8	2.4	3.5	2.2	0.6	3.8	3.6	0.3	5.6	0.5	3.1	3.7	0.8	4.7	7.4	20.0	8.6	5.4	2.8	3.3	4.4	3.3	4.4	0.0	1.0	0.0	7.0	7.3	7.4	2.4	0.0	4.0	7.9	1.8	9.8	11.4	5.0	3.5	302.5	5.2	0.9	0.0	1.8	20.4	5.5	6.6	2.3	2.9	4.3	11.1	3.4	1.8	1.8	78.4	4.4	2.4	1.7	1.0	2.8	2.4	2.2	1.1	2.5	5.0	9.8	6.5	6.6	37.0	52.7	7.8	7.4	1.8	3.9	10.9
TMLHE	"BBOX2, FLJ10727, TMLH, XAP130"	ENSG00000185973	"Trimethyllysine hydroxylase, epsilon"	Q9NVH6	X	155490115-155669944	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"	"Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034589, HPA040331"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA034589: AB_10670571, HPA040331: AB_2676929"	"unprognostic (1.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.97e-2)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.69e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.75e-2)"	10.1	15.0	8.5	6.7	10.5	6.7	10.4	17.1	13.5	11.3	10.5	10.0	9.1	10.7	10.9	10.1	9.5	9.5	7.4	22.3	10.3	7.5	15.8	16.9	6.9	14.6	12.5	7.4	12.4	10.7	18.4	17.5	7.6	11.5	7.7	11.6	10.6	16.2	9.6	28.1	7.8	10.0	13.8	13.7	9.2	9.8	3.1	11.2	12.2	10.5	5.3	8.7	10.2	9.1	9.1	10.3	14.7	15.7	4.3	5.6	4.5	15.2	7.5	6.2	18.1	7.7	11.9	0.0	6.2	9.1	7.8	20.4	5.3	8.6	0.0	25.0	10.8	18.0	8.3	13.2	6.0	8.9	6.2	9.0	6.8	12.2	6.2	10.8	6.4	4.9	12.6	12.7	8.7	13.2	11.7	12.3	9.8	9.5	5.6	12.9	5.7	7.7	7.2	1.9	13.2	0.1	7.7	9.9	5.8	9.4	5.2	5.9	8.9	5.8	0.3	6.7	7.0	6.7	7.3	10.3	6.6	6.3	13.0	7.6	7.0	7.5	5.8	8.0	10.0	6.0	1.9	10.1	11.3	3.9	11.4	2.9	6.2	4.3	3.3	10.3	9.1	5.6	4.9	14.7	4.3	15.7	4.7	4.2	4.5	8.5	10.5	17.1	13.5	10.3	7.5	12.5	7.4	11.5	11.2	0.0	2.9	10.0	9.7	4.6	3.6	6.5	7.6	9.4	4.5	8.7	0.0	7.2	19.9	8.9	0.0	5.6	8.6	0.0	6.6	5.8	7.5	2.7	9.3	11.3	10.9	0.0	5.8	5.5	14.6	0.0	7.8	11.4	11.8	10.8	6.9	7.2	8.0	7.0	5.3	11.3	5.2	0.0	8.2	0.4	1.7	3.6	5.6	6.9	7.6	8.7
